| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.677 | 0.003 | 0.705 | Anesthetic local | 0.705 0.003 DBMET00256 0.506 0.004 DBMET00257 0.249 0.02 DBMET01089 0.532 0.004 DBMET01090 0.332 0.01 DBMET01091 0.243 0.021 DBMET01128 0.214 0.029 DBMET01129 | DBMET00256 | |
| 0.582 | 0.008 | 0.61 | Calcium channel L-type activator | 0.557 0.012 DBMET00256 0.586 0.007 DBMET00257 0.61 0.005 DBMET01089 0.56 0.011 DBMET01090 0.61 0.005 DBMET01091 0.585 0.007 DBMET01128 0.599 0.006 DBMET01129 | DBMET01091 | |
| 0.52 | 0.008 | 0.52 | Sigma receptor agonist | 0.426 0.018 DBMET00256 0.177 0.07 DBMET00257 0.39 0.023 DBMET01089 0.118 0.117 DBMET01090 0.126 0.107 DBMET01091 0.275 0.044 DBMET01128 0.338 0.032 DBMET01129 | ||
| 0.502 | 0.008 | 0.502 | Anesthetic general | 0.482 0.009 DBMET00256 0.359 0.022 DBMET00257 0.412 0.015 DBMET01089 0.333 0.027 DBMET01090 0.373 0.02 DBMET01091 0.454 0.011 DBMET01128 0.442 0.012 DBMET01129 | ||
| 0.505 | 0.031 | 0.642 | 5 Hydroxytryptamine release inhibitor | 0.447 0.053 DBMET00256 0.394 0.082 DBMET00257 0.48 0.039 DBMET01089 0.34 0.125 DBMET01090 0.473 0.042 DBMET01091 0.642 0.007 DBMET01128 0.487 0.037 DBMET01129 | DBMET01128 | |
| 0.537 | 0.066 | 0.537 | Beta lactamase inhibitor | 0.341 0.118 DBMET00256 0.393 0.101 DBMET00257 0.223 0.171 DBMET01090 0.265 0.15 DBMET01091 | ||
| 0.467 | 0.019 | 0.467 | Cardiotonic | 0.412 0.027 DBMET00256 0.336 0.043 DBMET00257 0.304 0.054 DBMET01090 0.244 0.086 DBMET01091 | ||
| 0.474 | 0.032 | 0.474 | Calpain 2 inhibitor | 0.382 0.071 DBMET00256 0.461 0.036 DBMET00257 0.305 0.111 DBMET01089 0.366 0.079 DBMET01090 0.359 0.082 DBMET01091 0.24 0.156 DBMET01128 0.233 0.161 DBMET01129 | ||
| 0.407 | 0.022 | 0.451 | Calcium channel activator | 0.371 0.038 DBMET00256 0.363 0.041 DBMET00257 0.451 0.011 DBMET01089 0.327 0.067 DBMET01090 0.381 0.032 DBMET01091 0.42 0.018 DBMET01128 0.439 0.013 DBMET01129 | DBMET01089 | |
| 0.443 | 0.066 | 0.521 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.293 0.222 DBMET00256 0.44 0.068 DBMET00257 0.521 0.025 DBMET01089 0.29 0.227 DBMET01090 0.473 0.047 DBMET01091 0.505 0.031 DBMET01128 0.391 0.108 DBMET01129 | DBMET01089 | |
| 0.412 | 0.045 | 0.726 | Aldehyde oxidase inhibitor | 0.455 0.039 DBMET00256 0.158 0.132 DBMET00257 0.582 0.021 DBMET01089 0.177 0.118 DBMET01090 0.177 0.118 DBMET01091 0.64 0.014 DBMET01128 0.726 0.006 DBMET01129 | DBMET01129 | |
| 0.397 | 0.063 | 0.656 | GABA C receptor rho-3 antagonist | 0.326 0.099 DBMET00256 0.41 0.057 DBMET00257 0.64 0.005 DBMET01089 0.339 0.092 DBMET01090 0.446 0.043 DBMET01091 0.541 0.016 DBMET01128 0.656 0.004 DBMET01129 | DBMET01129 | |
| 0.349 | 0.016 | 0.448 | Tyrosine 3 hydroxylase inhibitor | 0.359 0.014 DBMET00256 0.277 0.046 DBMET00257 0.356 0.015 DBMET01089 0.285 0.041 DBMET01090 0.298 0.034 DBMET01091 0.304 0.031 DBMET01128 0.448 0.005 DBMET01129 | DBMET01129 | |
| 0.334 | 0.015 | 0.355 | Gastrin inhibitor | 0.277 0.051 DBMET00256 0.355 0.009 DBMET00257 0.299 0.033 DBMET01089 0.301 0.032 DBMET01090 0.3 0.033 DBMET01091 0.305 0.029 DBMET01128 0.253 0.076 DBMET01129 | DBMET00257 | |
| 0.316 | 0.019 | 0.372 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.344 0.014 DBMET00256 0.218 0.059 DBMET00257 0.312 0.02 DBMET01089 0.253 0.041 DBMET01090 0.274 0.033 DBMET01091 0.317 0.019 DBMET01128 0.372 0.01 DBMET01129 | DBMET01129 | |
| 0.408 | 0.116 | 0.408 | DNA polymerase beta inhibitor | 0.354 0.138 DBMET00256 0.322 0.153 DBMET00257 0.318 0.156 DBMET01089 0.271 0.18 DBMET01090 0.247 0.194 DBMET01091 0.355 0.137 DBMET01128 0.333 0.148 DBMET01129 | ||
| 0.343 | 0.055 | 0.388 | Spasmolytic | 0.388 0.043 DBMET00256 0.229 0.101 DBMET00257 0.179 0.137 DBMET01089 0.273 0.081 DBMET01090 0.197 0.122 DBMET01091 0.198 0.121 DBMET01128 0.207 0.114 DBMET01129 | DBMET00256 | |
| 0.392 | 0.116 | 0.474 | Caspase 9 stimulant | 0.36 0.138 DBMET00256 0.259 0.242 DBMET00257 0.395 0.114 DBMET01089 0.377 0.125 DBMET01091 0.271 0.228 DBMET01128 0.474 0.071 DBMET01129 | DBMET01129 | |
| 0.284 | 0.01 | 0.284 | Nav1.3 sodium channel blocker | 0.156 0.044 DBMET00256 0.276 0.011 DBMET00257 0.176 0.034 DBMET01089 0.151 0.047 DBMET01090 0.147 0.05 DBMET01091 0.121 0.073 DBMET01129 | ||
| 0.345 | 0.075 | 0.352 | Thyroid hormone antagonist | 0.352 0.072 DBMET00256 0.31 0.089 DBMET00257 0.318 0.085 DBMET01090 0.262 0.116 DBMET01091 | DBMET00256 | |
| 0.31 | 0.047 | 0.541 | Superoxide dismutase inhibitor | 0.346 0.037 DBMET00256 0.255 0.071 DBMET00257 0.389 0.029 DBMET01089 0.281 0.058 DBMET01090 0.31 0.047 DBMET01091 0.541 0.01 DBMET01128 0.476 0.015 DBMET01129 | DBMET01128 | |
| 0.298 | 0.041 | 0.373 | Anticonvulsant | 0.162 0.115 DBMET00256 0.273 0.048 DBMET00257 0.279 0.046 DBMET01089 0.149 0.13 DBMET01090 0.373 0.025 DBMET01091 0.192 0.089 DBMET01128 0.148 0.132 DBMET01129 | DBMET01091 | |
| 0.38 | 0.124 | 0.41 | DNA directed DNA polymerase inhibitor | 0.41 0.111 DBMET00256 0.286 0.169 DBMET00257 0.32 0.152 DBMET01089 0.318 0.153 DBMET01090 0.234 0.202 DBMET01091 0.369 0.129 DBMET01128 0.35 0.138 DBMET01129 | DBMET00256 | |
| 0.283 | 0.028 | 0.283 | Neuropeptide Y2 antagonist | 0.242 0.064 DBMET00256 0.274 0.035 DBMET00257 0.236 0.07 DBMET01089 0.227 0.08 DBMET01090 0.263 0.045 DBMET01091 0.175 0.17 DBMET01128 0.219 0.09 DBMET01129 | ||
| 0.266 | 0.011 | 0.482 | Ferrochelatase inhibitor | 0.137 0.044 DBMET00256 0.238 0.015 DBMET00257 0.383 0.004 DBMET01089 0.118 0.055 DBMET01090 0.349 0.005 DBMET01091 0.482 0.003 DBMET01128 0.288 0.009 DBMET01129 | DBMET01128 | |
| 0.274 | 0.024 | 0.274 | Cytidine deaminase inhibitor | 0.187 0.054 DBMET00256 0.132 0.09 DBMET00257 0.183 0.055 DBMET01089 0.129 0.092 DBMET01091 0.186 0.054 DBMET01128 0.131 0.09 DBMET01129 | ||
| 0.321 | 0.072 | 0.34 | Vasodilator, coronary | 0.285 0.101 DBMET00256 0.34 0.06 DBMET00257 0.286 0.099 DBMET01089 0.302 0.085 DBMET01090 0.246 0.138 DBMET01091 0.31 0.08 DBMET01128 0.306 0.083 DBMET01129 | DBMET00257 | |
| 0.325 | 0.077 | 0.325 | Thyroid hormone beta antagonist | 0.321 0.078 DBMET00256 0.298 0.089 DBMET00257 0.295 0.091 DBMET01090 0.24 0.125 DBMET01091 | ||
| 0.303 | 0.057 | 0.341 | Insulysin inhibitor | 0.282 0.07 DBMET00256 0.29 0.065 DBMET00257 0.301 0.058 DBMET01089 0.267 0.082 DBMET01090 0.31 0.053 DBMET01091 0.341 0.037 DBMET01128 0.312 0.052 DBMET01129 | DBMET01128 | |
| 0.286 | 0.04 | 0.696 | Peroxidase inhibitor | 0.355 0.027 DBMET00256 0.187 0.063 DBMET00257 0.545 0.006 DBMET01089 0.263 0.045 DBMET01090 0.281 0.041 DBMET01091 0.486 0.011 DBMET01128 0.696 0.003 DBMET01129 | DBMET01129 | |
| 0.367 | 0.123 | 0.367 | Transcription factor inhibitor | 0.319 0.145 DBMET00256 0.299 0.155 DBMET00257 0.231 0.201 DBMET01089 0.259 0.18 DBMET01090 0.242 0.192 DBMET01091 | ||
| 0.263 | 0.02 | 0.263 | Nav1.2 sodium channel blocker | 0.143 0.061 DBMET00256 0.129 0.073 DBMET00257 0.176 0.044 DBMET01089 0.189 0.039 DBMET01091 0.118 0.086 DBMET01129 | ||
| 0.284 | 0.042 | 0.285 | 5 Hydroxytryptamine 1E antagonist | 0.232 0.095 DBMET00256 0.215 0.114 DBMET00257 0.285 0.041 DBMET01089 0.275 0.049 DBMET01091 0.266 0.058 DBMET01129 | DBMET01089 | |
| 0.248 | 0.008 | 0.607 | Porphobilinogen synthase inhibitor | 0.366 0.004 DBMET00256 0.116 0.029 DBMET00257 0.245 0.008 DBMET01089 0.181 0.015 DBMET01090 0.218 0.01 DBMET01091 0.607 0.003 DBMET01128 0.294 0.005 DBMET01129 | DBMET01128 | |
| 0.295 | 0.066 | 0.422 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.33 0.056 DBMET00256 0.194 0.104 DBMET00257 0.378 0.043 DBMET01089 0.219 0.09 DBMET01090 0.181 0.113 DBMET01091 0.416 0.035 DBMET01128 0.422 0.033 DBMET01129 | DBMET01129 | |
| 0.232 | 0.004 | 0.234 | Acetyl-CoA transferase inhibitor | 0.157 0.005 DBMET00256 0.234 0.004 DBMET00257 0.097 0.014 DBMET01089 0.158 0.005 DBMET01090 0.218 0.004 DBMET01091 | DBMET00257 | |
| 0.28 | 0.056 | 0.405 | 5 Hydroxytryptamine uptake stimulant | 0.29 0.05 DBMET00256 0.336 0.03 DBMET00257 0.405 0.013 DBMET01089 0.348 0.026 DBMET01090 0.318 0.036 DBMET01091 0.388 0.016 DBMET01128 0.386 0.017 DBMET01129 | DBMET01089 | |
| 0.246 | 0.023 | 0.544 | Alpha-N-acetylglucosaminidase inhibitor | 0.191 0.037 DBMET00256 0.264 0.021 DBMET00257 0.33 0.013 DBMET01089 0.205 0.033 DBMET01090 0.244 0.024 DBMET01091 0.544 0.004 DBMET01128 0.295 0.017 DBMET01129 | DBMET01128 | |
| 0.331 | 0.109 | 0.595 | Histamine release inhibitor | 0.328 0.11 DBMET00256 0.219 0.182 DBMET00257 0.433 0.059 DBMET01089 0.217 0.184 DBMET01090 0.323 0.112 DBMET01091 0.595 0.01 DBMET01128 0.47 0.041 DBMET01129 | DBMET01128 | |
| 0.27 | 0.048 | 0.288 | Calpain inhibitor | 0.216 0.098 DBMET00256 0.288 0.036 DBMET00257 0.209 0.105 DBMET01089 0.243 0.072 DBMET01090 0.244 0.071 DBMET01091 0.169 0.15 DBMET01129 | DBMET00257 | |
| 0.24 | 0.021 | 0.286 | 5 Hydroxytryptamine 3E antagonist | 0.182 0.1 DBMET00256 0.286 0.006 DBMET00257 0.264 0.011 DBMET01089 0.219 0.038 DBMET01090 0.273 0.009 DBMET01091 0.172 0.128 DBMET01128 0.202 0.06 DBMET01129 | DBMET00257 | |
| 0.267 | 0.067 | 0.404 | Interleukin agonist | 0.25 0.079 DBMET00256 0.231 0.093 DBMET00257 0.33 0.035 DBMET01089 0.213 0.109 DBMET01090 0.306 0.045 DBMET01091 0.404 0.018 DBMET01128 0.337 0.033 DBMET01129 | DBMET01128 | |
| 0.204 | 0.013 | 0.204 | Telomerase inhibitor | 0.127 0.024 DBMET00256 0.154 0.02 DBMET00257 0.098 0.034 DBMET01090 0.124 0.025 DBMET01091 | ||
| 0.214 | 0.026 | 0.222 | Death-associated protein kinase 2 inhibitor | 0.193 0.04 DBMET00256 0.164 0.077 DBMET00257 0.153 0.099 DBMET01090 0.222 0.022 DBMET01091 0.166 0.074 DBMET01129 | DBMET01091 | |
| 0.228 | 0.041 | 0.308 | Lipocortins synthesis antagonist | 0.205 0.053 DBMET00256 0.268 0.028 DBMET01089 0.308 0.02 DBMET01128 0.25 0.033 DBMET01129 | DBMET01128 | |
| 0.241 | 0.057 | 0.311 | Peptidyltransferase inhibitor | 0.243 0.056 DBMET00256 0.311 0.021 DBMET00257 0.3 0.024 DBMET01090 0.284 0.031 DBMET01091 0.187 0.117 DBMET01128 0.223 0.074 DBMET01129 | DBMET00257 | |
| 0.203 | 0.022 | 0.213 | Toll-Like receptor 2 antagonist | 0.213 0.018 DBMET00256 0.196 0.025 DBMET00257 0.152 0.051 DBMET01089 0.206 0.021 DBMET01090 0.21 0.019 DBMET01091 0.13 0.068 DBMET01128 0.21 0.019 DBMET01129 | DBMET00256 | |
| 0.188 | 0.01 | 0.329 | Electrolyte absorption antagonist | 0.157 0.017 DBMET00256 0.129 0.03 DBMET00257 0.195 0.009 DBMET01089 0.107 0.049 DBMET01090 0.135 0.026 DBMET01091 0.329 0.004 DBMET01128 0.147 0.02 DBMET01129 | DBMET01128 | |
| 0.324 | 0.148 | 0.449 | Alpha-glucosidase inhibitor | 0.365 0.129 DBMET00256 0.259 0.182 DBMET00257 0.319 0.15 DBMET01089 0.3 0.16 DBMET01090 0.222 0.205 DBMET01091 0.331 0.145 DBMET01128 0.449 0.096 DBMET01129 | DBMET01129 | |
| 0.253 | 0.079 | 0.293 | DNA damaging | 0.293 0.06 DBMET00256 0.228 0.094 DBMET00257 0.192 0.122 DBMET01089 0.265 0.073 DBMET01090 0.222 0.099 DBMET01091 0.207 0.11 DBMET01129 | DBMET00256 | |
| 0.186 | 0.012 | 0.219 | Sphingosine 1-phosphate receptor 4 antagonist | 0.156 0.029 DBMET00256 0.191 0.011 DBMET00257 0.172 0.018 DBMET01089 0.16 0.025 DBMET01090 0.219 0.006 DBMET01091 0.165 0.022 DBMET01128 0.154 0.03 DBMET01129 | DBMET01091 | |
| 0.188 | 0.024 | 0.188 | Nav1.6 sodium channel blocker | 0.125 0.088 DBMET00256 0.116 0.102 DBMET00257 0.185 0.025 DBMET01089 0.134 0.074 DBMET01091 0.162 0.041 DBMET01129 | ||
| 0.222 | 0.059 | 0.287 | DNA methyltransferase I inhibitor | 0.224 0.058 DBMET00256 0.143 0.112 DBMET00257 0.171 0.086 DBMET01089 0.144 0.111 DBMET01090 0.287 0.031 DBMET01128 0.245 0.049 DBMET01129 | DBMET01128 | |
| 0.184 | 0.022 | 0.233 | Nav1.1 sodium channel blocker | 0.126 0.044 DBMET00256 0.233 0.014 DBMET01089 0.164 0.028 DBMET01091 0.095 0.072 DBMET01128 0.188 0.021 DBMET01129 | DBMET01089 | |
| 0.197 | 0.039 | 0.197 | ATPase inhibitor | 0.186 0.051 DBMET00256 0.164 0.079 DBMET00257 0.171 0.07 DBMET01089 0.152 0.098 DBMET01090 0.153 0.097 DBMET01091 0.137 0.126 DBMET01128 0.186 0.05 DBMET01129 | ||
| 0.221 | 0.07 | 0.221 | ErbB-1 antagonist | 0.188 0.104 DBMET00256 0.204 0.084 DBMET01089 0.192 0.098 DBMET01129 | ||
| 0.229 | 0.078 | 0.239 | Hypolipemic | 0.211 0.086 DBMET00256 0.239 0.073 DBMET00257 0.22 0.082 DBMET01090 0.152 0.135 DBMET01091 0.186 0.105 DBMET01128 | DBMET00257 | |
| 0.271 | 0.121 | 0.271 | Thioredoxin glutathione reductase inhibitor | 0.246 0.137 DBMET00256 0.194 0.178 DBMET00257 0.25 0.134 DBMET01089 0.222 0.154 DBMET01128 0.24 0.141 DBMET01129 | ||
| 0.167 | 0.024 | 0.202 | Sphingosine 1-phosphate receptor 2 antagonist | 0.149 0.042 DBMET00256 0.202 0.007 DBMET00257 0.169 0.022 DBMET01089 0.182 0.014 DBMET01090 0.18 0.015 DBMET01091 0.163 0.027 DBMET01128 0.17 0.021 DBMET01129 | DBMET00257 | |
| 0.171 | 0.032 | 0.196 | Sphingosine 1-phosphate receptor 5 antagonist | 0.153 0.057 DBMET00256 0.176 0.027 DBMET00257 0.182 0.022 DBMET01089 0.158 0.049 DBMET01090 0.194 0.014 DBMET01091 0.196 0.013 DBMET01128 0.176 0.027 DBMET01129 | DBMET01128 | |
| 0.169 | 0.03 | 0.272 | Chelator | 0.272 0.014 DBMET00256 0.101 0.077 DBMET00257 0.182 0.028 DBMET01090 0.1 0.077 DBMET01129 | DBMET00256 | |
| 0.209 | 0.073 | 0.264 | DNA methylase inhibitor | 0.205 0.076 DBMET00256 0.172 0.099 DBMET01089 0.264 0.041 DBMET01128 0.226 0.063 DBMET01129 | DBMET01128 | |
| 0.169 | 0.034 | 0.169 | Cyclooxygenase 3 inhibitor | 0.155 0.044 DBMET00256 0.138 0.059 DBMET00257 0.158 0.042 DBMET01089 0.122 0.076 DBMET01090 0.143 0.055 DBMET01091 0.165 0.037 DBMET01128 0.167 0.035 DBMET01129 | ||
| 0.208 | 0.074 | 0.413 | Amyloid beta aggregation inhibitor | 0.413 0.023 DBMET00256 0.341 0.037 DBMET01090 0.187 0.085 DBMET01129 | DBMET00256 | |
| 0.15 | 0.023 | 0.15 | Calcium antagonist | 0.122 0.034 DBMET00257 0.102 0.046 DBMET01089 0.085 0.059 DBMET01091 | ||
| 0.149 | 0.027 | 0.179 | Gastric antisecretory | 0.095 0.072 DBMET00256 0.13 0.036 DBMET00257 0.179 0.017 DBMET01089 0.115 0.047 DBMET01091 0.118 0.045 DBMET01128 0.156 0.024 DBMET01129 | DBMET01089 | |
| 0.146 | 0.025 | 0.2 | Urease inhibitor | 0.146 0.025 DBMET00256 0.158 0.02 DBMET00257 0.133 0.033 DBMET01089 0.157 0.02 DBMET01090 0.2 0.01 DBMET01091 0.143 0.027 DBMET01128 0.149 0.023 DBMET01129 | DBMET01091 | |
| 0.14 | 0.02 | 0.291 | NADH dehydrogenase inhibitor | 0.139 0.021 DBMET00256 0.09 0.056 DBMET00257 0.202 0.01 DBMET01089 0.089 0.057 DBMET01090 0.102 0.042 DBMET01091 0.291 0.007 DBMET01128 0.215 0.009 DBMET01129 | DBMET01128 | |
| 0.143 | 0.025 | 0.163 | Prolactin inhibitor | 0.129 0.032 DBMET00256 0.104 0.052 DBMET00257 0.122 0.037 DBMET01089 0.092 0.064 DBMET01090 0.086 0.072 DBMET01091 0.163 0.017 DBMET01129 | DBMET01129 | |
| 0.125 | 0.007 | 0.125 | CC chemokine 5 receptor agonist | 0.112 0.012 DBMET00256 0.101 0.021 DBMET00257 0.106 0.016 DBMET01089 0.091 0.036 DBMET01090 0.099 0.022 DBMET01091 0.105 0.017 DBMET01129 | ||
| 0.15 | 0.034 | 0.182 | Nav1.4 sodium channel blocker | 0.135 0.041 DBMET00256 0.118 0.054 DBMET00257 0.095 0.083 DBMET01089 0.11 0.063 DBMET01090 0.182 0.023 DBMET01091 0.118 0.054 DBMET01129 | DBMET01091 | |
| 0.201 | 0.087 | 0.328 | Nitric-oxide synthase stimulant | 0.19 0.107 DBMET00256 0.218 0.063 DBMET00257 0.296 0.012 DBMET01089 0.207 0.078 DBMET01090 0.237 0.043 DBMET01091 0.233 0.046 DBMET01128 0.328 0.007 DBMET01129 | DBMET01129 | |
| 0.176 | 0.068 | 0.225 | Antipruritic | 0.225 0.034 DBMET00257 0.144 0.101 DBMET01089 0.154 0.09 DBMET01090 0.207 0.044 DBMET01091 0.169 0.075 DBMET01128 0.139 0.108 DBMET01129 | DBMET00257 | |
| 0.13 | 0.023 | 0.132 | Potassium channel (Voltage-sensitive) activator | 0.088 0.073 DBMET00256 0.13 0.023 DBMET00257 0.132 0.022 DBMET01089 0.087 0.073 DBMET01090 0.123 0.029 DBMET01091 0.088 0.072 DBMET01129 | DBMET01089 | |
| 0.163 | 0.058 | 0.217 | Lck kinase inhibitor | 0.115 0.089 DBMET00257 0.217 0.034 DBMET01089 0.161 0.059 DBMET01091 0.147 0.067 DBMET01129 | DBMET01089 | |
| 0.192 | 0.087 | 0.278 | MAP kinase kinase 2 inhibitor | 0.182 0.094 DBMET00257 0.278 0.043 DBMET01089 0.182 0.094 DBMET01091 0.247 0.055 DBMET01128 0.254 0.052 DBMET01129 | DBMET01089 | |
| 0.116 | 0.011 | 0.134 | Maillard reaction inhibitor | 0.134 0.008 DBMET00256 0.115 0.012 DBMET00257 0.076 0.026 DBMET01089 0.133 0.008 DBMET01090 0.134 0.008 DBMET01091 0.116 0.011 DBMET01128 0.111 0.013 DBMET01129 | DBMET01091 | |
| 0.162 | 0.059 | 0.287 | GABA C receptor rho-2 antagonist | 0.204 0.027 DBMET00257 0.287 0.006 DBMET01089 0.156 0.066 DBMET01090 0.157 0.065 DBMET01091 0.239 0.014 DBMET01128 0.279 0.007 DBMET01129 | DBMET01089 | |
| 0.105 | 0.004 | 0.105 | Acetyl-CoA transferase 1 inhibitor | 0.063 0.008 DBMET00256 0.105 0.004 DBMET00257 0.048 0.019 DBMET01089 0.063 0.008 DBMET01090 0.104 0.004 DBMET01091 | ||
| 0.114 | 0.019 | 0.386 | GABA aminotransferase inhibitor | 0.102 0.025 DBMET00256 0.136 0.011 DBMET00257 0.191 0.005 DBMET01089 0.123 0.015 DBMET01090 0.248 0.004 DBMET01091 0.386 0.003 DBMET01128 0.255 0.004 DBMET01129 | DBMET01128 | |
| 0.143 | 0.051 | 0.17 | Alkylator | 0.17 0.037 DBMET00256 0.123 0.065 DBMET00257 0.117 0.071 DBMET01089 0.147 0.048 DBMET01090 0.114 0.074 DBMET01091 0.109 0.079 DBMET01128 0.144 0.049 DBMET01129 | DBMET00256 | |
| 0.131 | 0.041 | 0.131 | Butyrylcholinesterase inhibitor | 0.125 0.044 DBMET00256 0.084 0.077 DBMET00257 0.088 0.072 DBMET01090 | ||
| 0.153 | 0.064 | 0.203 | Hemostatic | 0.121 0.111 DBMET00257 0.152 0.065 DBMET01089 0.203 0.031 DBMET01091 0.155 0.062 DBMET01128 0.164 0.053 DBMET01129 | DBMET01091 | |
| 0.112 | 0.023 | 0.112 | Glycine receptor antagonist | 0.089 0.044 DBMET00256 0.08 0.056 DBMET00257 0.099 0.033 DBMET01089 0.081 0.054 DBMET01091 0.084 0.051 DBMET01128 0.084 0.051 DBMET01129 | ||
| 0.118 | 0.031 | 0.148 | Histamine N-methyltransferase inhibitor | 0.09 0.056 DBMET00256 0.148 0.015 DBMET01089 0.124 0.027 DBMET01091 0.123 0.028 DBMET01128 0.13 0.023 DBMET01129 | DBMET01089 | |
| 0.132 | 0.046 | 0.171 | TRPA1 agonist | 0.131 0.046 DBMET00256 0.109 0.072 DBMET00257 0.15 0.031 DBMET01089 0.109 0.073 DBMET01090 0.131 0.047 DBMET01091 0.17 0.019 DBMET01128 0.171 0.019 DBMET01129 | DBMET01129 | |
| 0.203 | 0.119 | 0.554 | 5 Hydroxytryptamine release stimulant | 0.426 0.041 DBMET00257 0.554 0.02 DBMET01089 0.278 0.077 DBMET01090 0.338 0.059 DBMET01091 0.256 0.086 DBMET01128 0.517 0.025 DBMET01129 | DBMET01089 | |
| 0.138 | 0.054 | 0.152 | Proteasome inhibitor | 0.143 0.051 DBMET00256 0.148 0.048 DBMET00257 0.152 0.045 DBMET01090 0.101 0.085 DBMET01091 | DBMET01090 | |
| 0.111 | 0.029 | 0.158 | Glutamate release inhibitor | 0.104 0.037 DBMET00256 0.114 0.026 DBMET00257 0.158 0.008 DBMET01089 0.107 0.033 DBMET01090 0.124 0.02 DBMET01091 0.135 0.014 DBMET01128 0.131 0.016 DBMET01129 | DBMET01089 | |
| 0.11 | 0.029 | 0.113 | Glutathione S-transferase inhibitor | 0.113 0.027 DBMET00256 0.107 0.031 DBMET00257 0.075 0.07 DBMET01089 0.11 0.029 DBMET01090 0.107 0.031 DBMET01091 0.077 0.066 DBMET01129 | DBMET00256 | |
| 0.143 | 0.064 | 0.198 | Heat shock protein 70 antagonist | 0.146 0.055 DBMET00256 0.154 0.037 DBMET00257 0.169 0.018 DBMET01089 0.157 0.032 DBMET01090 0.198 0.007 DBMET01091 0.177 0.013 DBMET01128 0.181 0.011 DBMET01129 | DBMET01091 | |
| 0.247 | 0.167 | 0.555 | 15-Lipoxygenase inhibitor | 0.314 0.122 DBMET00256 0.407 0.072 DBMET01089 0.237 0.176 DBMET01090 0.373 0.087 DBMET01128 0.555 0.031 DBMET01129 | DBMET01129 | |
| 0.2 | 0.12 | 0.28 | Immunostimulant | 0.21 0.114 DBMET00256 0.216 0.111 DBMET00257 0.185 0.13 DBMET01089 0.228 0.106 DBMET01090 0.28 0.085 DBMET01091 0.236 0.102 DBMET01128 0.248 0.097 DBMET01129 | DBMET01091 | |
| 0.147 | 0.07 | 0.176 | Neuropeptide Y1 antagonist | 0.176 0.034 DBMET00257 0.153 0.061 DBMET01089 0.148 0.067 DBMET01090 0.154 0.059 DBMET01091 0.141 0.079 DBMET01128 0.15 0.065 DBMET01129 | DBMET00257 | |
| 0.124 | 0.05 | 0.152 | CDK3/cyclin E inhibitor | 0.152 0.025 DBMET00257 0.122 0.053 DBMET01090 0.135 0.039 DBMET01091 | DBMET00257 | |
| 0.172 | 0.099 | 0.18 | Growth factor agonist | 0.18 0.087 DBMET01089 0.162 0.116 DBMET01129 | DBMET01089 | |
| 0.092 | 0.021 | 0.152 | NMDA receptor glycine site agonist | 0.06 0.045 DBMET00256 0.12 0.009 DBMET00257 0.12 0.009 DBMET01089 0.091 0.021 DBMET01090 0.152 0.004 DBMET01091 0.146 0.005 DBMET01128 0.105 0.014 DBMET01129 | DBMET01091 | |
| 0.085 | 0.015 | 0.092 | Gonadotropin-releasing hormone receptor agonist | 0.071 0.025 DBMET00256 0.092 0.013 DBMET00257 0.058 0.043 DBMET01089 0.075 0.021 DBMET01090 0.057 0.047 DBMET01091 0.059 0.042 DBMET01129 | DBMET00257 | |
| 0.091 | 0.023 | 0.19 | NMDA receptor agonist | 0.061 0.045 DBMET00256 0.152 0.008 DBMET00257 0.119 0.014 DBMET01089 0.108 0.016 DBMET01090 0.19 0.005 DBMET01091 0.187 0.005 DBMET01128 0.106 0.017 DBMET01129 | DBMET01091 | |
| 0.156 | 0.088 | 0.204 | Neurotensin receptor agonist | 0.154 0.092 DBMET00256 0.174 0.057 DBMET00257 0.182 0.048 DBMET01089 0.172 0.06 DBMET01090 0.18 0.05 DBMET01091 0.174 0.056 DBMET01128 0.204 0.033 DBMET01129 | DBMET01129 | |
| 0.088 | 0.021 | 0.162 | Potassium channel (ATP-sensitive) blocker | 0.085 0.024 DBMET00256 0.075 0.034 DBMET00257 0.162 0.004 DBMET01089 0.073 0.037 DBMET01090 0.066 0.049 DBMET01091 0.094 0.019 DBMET01128 0.14 0.005 DBMET01129 | DBMET01089 | |
| 0.168 | 0.102 | 0.204 | Focal adhesion kinase 2 inhibitor | 0.204 0.066 DBMET01089 0.148 0.133 DBMET01128 0.145 0.138 DBMET01129 | DBMET01089 | |
| 0.088 | 0.022 | 0.096 | Bombesin 1 receptor agonist | 0.066 0.035 DBMET00256 0.096 0.019 DBMET00257 0.071 0.03 DBMET01090 0.085 0.023 DBMET01091 | DBMET00257 | |
| 0.129 | 0.065 | 0.206 | Cathepsin H inhibitor | 0.137 0.056 DBMET00257 0.194 0.024 DBMET01089 0.181 0.029 DBMET01091 0.206 0.021 DBMET01128 0.148 0.047 DBMET01129 | DBMET01128 | |
| 0.093 | 0.029 | 0.273 | Phenylalanine 4-hydroxylase inhibitor | 0.107 0.023 DBMET00256 0.158 0.011 DBMET01089 0.06 0.058 DBMET01090 0.105 0.023 DBMET01091 0.218 0.006 DBMET01128 0.273 0.004 DBMET01129 | DBMET01129 | |
| 0.139 | 0.078 | 0.195 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET00256 0.136 0.091 DBMET00257 0.183 0.006 DBMET01089 0.131 0.115 DBMET01090 0.141 0.068 DBMET01091 0.195 0.004 DBMET01128 0.181 0.007 DBMET01129 | DBMET01128 | |
| 0.094 | 0.034 | 0.151 | Estrogen-related receptor beta agonist | 0.103 0.022 DBMET00256 0.095 0.032 DBMET00257 0.119 0.01 DBMET01089 0.104 0.021 DBMET01090 0.085 0.052 DBMET01091 0.103 0.021 DBMET01128 0.151 0.004 DBMET01129 | DBMET01129 | |
| 0.13 | 0.07 | 0.13 | Acetylcholinesterase inhibitor | 0.118 0.079 DBMET00256 0.129 0.07 DBMET01089 0.121 0.077 DBMET01129 | ||
| 0.114 | 0.055 | 0.114 | Interleukin 2 antagonist | 0.104 0.08 DBMET00257 0.099 0.095 DBMET01089 | ||
| 0.091 | 0.033 | 0.139 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET00256 0.078 0.044 DBMET00257 0.111 0.023 DBMET01089 0.101 0.027 DBMET01091 0.139 0.015 DBMET01128 0.103 0.026 DBMET01129 | DBMET01128 | |
| 0.102 | 0.046 | 0.119 | Potassium channel activator | 0.087 0.064 DBMET00256 0.113 0.037 DBMET00257 0.119 0.033 DBMET01089 0.096 0.052 DBMET01090 0.105 0.043 DBMET01091 0.08 0.076 DBMET01128 0.096 0.053 DBMET01129 | DBMET01089 | |
| 0.07 | 0.015 | 0.074 | Carbonic anhydrase IV inhibitor | 0.042 0.031 DBMET00256 0.072 0.014 DBMET00257 0.044 0.029 DBMET01090 0.074 0.013 DBMET01091 0.041 0.032 DBMET01128 | DBMET01091 | |
| 0.172 | 0.119 | 0.247 | Cyclic AMP phosphodiesterase inhibitor | 0.222 0.079 DBMET01089 0.201 0.093 DBMET01128 0.247 0.065 DBMET01129 | DBMET01129 | |
| 0.066 | 0.015 | 0.072 | Sodium/calcium exchanger inhibitor | 0.054 0.027 DBMET00256 0.046 0.044 DBMET00257 0.072 0.011 DBMET01089 0.063 0.017 DBMET01091 0.047 0.041 DBMET01129 | DBMET01089 | |
| 0.117 | 0.067 | 0.117 | Calcium channel N-type blocker | 0.111 0.076 DBMET00257 | ||
| 0.103 | 0.053 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.077 DBMET00256 0.098 0.06 DBMET00257 0.107 0.049 DBMET01089 0.092 0.068 DBMET01128 0.106 0.05 DBMET01129 | DBMET01089 | |
| 0.099 | 0.049 | 0.429 | Triose-phosphate isomerase inhibitor | 0.085 0.068 DBMET00256 0.098 0.05 DBMET00257 0.217 0.009 DBMET01089 0.084 0.068 DBMET01090 0.132 0.026 DBMET01091 0.429 0.003 DBMET01128 0.184 0.013 DBMET01129 | DBMET01128 | |
| 0.076 | 0.028 | 0.097 | Carbonic anhydrase stimulant | 0.076 0.028 DBMET00257 0.087 0.023 DBMET01089 0.097 0.019 DBMET01091 0.063 0.037 DBMET01128 0.073 0.029 DBMET01129 | DBMET01091 | |
| 0.108 | 0.06 | 0.222 | Aminopeptidase B inhibitor | 0.091 0.072 DBMET00257 0.16 0.033 DBMET01089 0.161 0.033 DBMET01091 0.222 0.017 DBMET01128 0.154 0.036 DBMET01129 | DBMET01128 | |
| 0.088 | 0.041 | 0.109 | Interferon agonist | 0.074 0.063 DBMET00257 0.109 0.022 DBMET01089 0.071 0.068 DBMET01091 0.09 0.038 DBMET01128 0.095 0.033 DBMET01129 | DBMET01089 | |
| 0.153 | 0.106 | 0.36 | Succinate dehydrogenase inhibitor | 0.169 0.082 DBMET00256 0.152 0.108 DBMET00257 0.238 0.027 DBMET01089 0.168 0.083 DBMET01090 0.185 0.063 DBMET01091 0.36 0.005 DBMET01128 0.261 0.019 DBMET01129 | DBMET01128 | |
| 0.105 | 0.059 | 0.328 | Adenylate kinase inhibitor | 0.203 0.014 DBMET01089 0.115 0.048 DBMET01091 0.328 0.005 DBMET01128 0.192 0.016 DBMET01129 | DBMET01128 | |
| 0.067 | 0.02 | 0.106 | Dihydroorotate oxidase inhibitor | 0.07 0.017 DBMET00256 0.065 0.022 DBMET00257 0.09 0.007 DBMET01089 0.068 0.019 DBMET01090 0.075 0.014 DBMET01091 0.106 0.004 DBMET01128 0.098 0.005 DBMET01129 | DBMET01128 | |
| 0.05 | 0.005 | 0.05 | Adenosine uptake inhibitor | 0.035 0.022 DBMET00256 0.044 0.008 DBMET00257 0.047 0.005 DBMET01089 0.049 0.005 DBMET01091 0.04 0.011 DBMET01129 | ||
| 0.118 | 0.073 | 0.289 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 DBMET00256 0.171 0.037 DBMET01089 0.289 0.013 DBMET01128 0.231 0.021 DBMET01129 | DBMET01128 | |
| 0.088 | 0.042 | 0.129 | T cell inhibitor | 0.079 0.068 DBMET00257 0.129 0.012 DBMET01089 0.082 0.06 DBMET01091 0.088 0.041 DBMET01128 0.092 0.033 DBMET01129 | DBMET01089 | |
| 0.102 | 0.057 | 0.161 | Glutamate (mGluR7) agonist | 0.161 0.009 DBMET00257 0.119 0.031 DBMET01089 0.106 0.048 DBMET01090 0.117 0.033 DBMET01091 0.089 0.088 DBMET01129 | DBMET00257 | |
| 0.1 | 0.059 | 0.1 | Sphingomyelinase inhibitor | 0.098 0.062 DBMET01089 0.085 0.08 DBMET01129 | ||
| 0.097 | 0.057 | 0.097 | Phosphodiesterase 6D inhibitor | 0.088 0.08 DBMET00256 0.09 0.076 DBMET01089 0.087 0.085 DBMET01128 0.093 0.067 DBMET01129 | ||
| 0.164 | 0.125 | 0.261 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.261 0.055 DBMET01089 0.203 0.089 DBMET01091 0.182 0.106 DBMET01129 | DBMET01089 | |
| 0.053 | 0.014 | 0.057 | Potassium channel KCNQ activator | 0.055 0.013 DBMET00257 0.057 0.012 DBMET01089 0.048 0.017 DBMET01091 | DBMET01089 | |
| 0.053 | 0.014 | 0.057 | Delayed rectifier potassium channel activator | 0.055 0.013 DBMET00257 0.057 0.012 DBMET01089 0.048 0.017 DBMET01091 | DBMET01089 | |
| 0.207 | 0.168 | 0.282 | Vasodilator, peripheral | 0.199 0.177 DBMET00257 0.249 0.128 DBMET01089 0.251 0.126 DBMET01128 0.282 0.106 DBMET01129 | DBMET01129 | |
| 0.108 | 0.07 | 0.147 | Acetylcholine release stimulant | 0.147 0.019 DBMET01089 0.1 0.087 DBMET01128 0.118 0.052 DBMET01129 | DBMET01089 | |
| 0.056 | 0.018 | 0.056 | Benzodiazepine antagonist | |||
| 0.102 | 0.065 | 0.557 | GABA C receptor agonist | 0.086 0.085 DBMET00256 0.102 0.065 DBMET00257 0.342 0.007 DBMET01089 0.086 0.085 DBMET01090 0.281 0.011 DBMET01091 0.557 0.003 DBMET01128 0.371 0.006 DBMET01129 | DBMET01128 | |
| 0.069 | 0.033 | 0.374 | Biliverdin reductase inhibitor | 0.06 0.04 DBMET00257 0.205 0.005 DBMET01089 0.115 0.015 DBMET01091 0.374 0.002 DBMET01128 0.163 0.008 DBMET01129 | DBMET01128 | |
| 0.164 | 0.129 | 0.283 | Antiamyloidogenic | 0.283 0.058 DBMET00256 0.232 0.08 DBMET01090 0.169 0.124 DBMET01128 0.21 0.093 DBMET01129 | DBMET00256 | |
| 0.065 | 0.03 | 0.17 | Acyl-CoA dehydrogenase inhibitor | 0.067 0.029 DBMET00257 0.12 0.013 DBMET01089 0.073 0.025 DBMET01091 0.17 0.007 DBMET01128 0.097 0.017 DBMET01129 | DBMET01128 | |
| 0.097 | 0.062 | 0.097 | Platelet activating factor alpha antagonist | |||
| 0.099 | 0.064 | 0.264 | GABA C receptor rho-1 antagonist | 0.133 0.03 DBMET00257 0.24 0.005 DBMET01089 0.091 0.076 DBMET01090 0.161 0.017 DBMET01091 0.264 0.004 DBMET01128 0.227 0.005 DBMET01129 | DBMET01128 | |
| 0.121 | 0.087 | 0.121 | Calcium channel blocker | |||
| 0.175 | 0.142 | 0.422 | RNA-directed DNA polymerase inhibitor | 0.173 0.146 DBMET00256 0.373 0.021 DBMET01089 0.194 0.108 DBMET01091 0.344 0.025 DBMET01128 0.422 0.016 DBMET01129 | DBMET01129 | |
| 0.097 | 0.066 | 0.295 | Carbonic anhydrase III inhibitor | 0.122 0.043 DBMET00256 0.115 0.048 DBMET00257 0.2 0.016 DBMET01089 0.145 0.03 DBMET01090 0.232 0.011 DBMET01091 0.247 0.009 DBMET01128 0.295 0.005 DBMET01129 | DBMET01129 | |
| 0.04 | 0.009 | 0.088 | Methionyl aminopeptidase 2 inhibitor | 0.036 0.01 DBMET01089 0.088 0.004 DBMET01128 | DBMET01128 | |
| 0.118 | 0.088 | 0.14 | Toll-Like receptor antagonist | 0.14 0.063 DBMET01089 0.112 0.099 DBMET01091 0.133 0.069 DBMET01129 | DBMET01089 | |
| 0.041 | 0.011 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 DBMET00257 0.031 0.024 DBMET01089 0.04 0.012 DBMET01091 0.03 0.025 DBMET01128 | ||
| 0.063 | 0.033 | 0.07 | Carbonic anhydrase I inhibitor | 0.052 0.041 DBMET00257 0.07 0.029 DBMET01091 | DBMET01091 | |
| 0.103 | 0.073 | 0.177 | Mucolytic | 0.118 0.056 DBMET00256 0.14 0.039 DBMET00257 0.144 0.036 DBMET01089 0.157 0.028 DBMET01090 0.132 0.044 DBMET01091 0.177 0.02 DBMET01128 0.169 0.023 DBMET01129 | DBMET01128 | |
| 0.064 | 0.034 | 0.126 | Heat shock protein 90 beta antagonist | 0.094 0.013 DBMET00256 0.076 0.023 DBMET00257 0.08 0.02 DBMET01089 0.109 0.009 DBMET01090 0.068 0.03 DBMET01091 0.126 0.006 DBMET01129 | DBMET01129 | |
| 0.129 | 0.1 | 0.152 | Src kinase inhibitor | 0.152 0.082 DBMET01089 0.12 0.108 DBMET01129 | DBMET01089 | |
| 0.067 | 0.037 | 0.08 | Cannabinoid CB1 receptor agonist | 0.08 0.029 DBMET00257 0.053 0.049 DBMET01091 | DBMET00257 | |
| 0.067 | 0.039 | 0.089 | Interferon inducer | 0.061 0.052 DBMET00257 0.089 0.018 DBMET01089 0.06 0.054 DBMET01091 0.072 0.032 DBMET01128 0.077 0.026 DBMET01129 | DBMET01089 | |
| 0.117 | 0.09 | 0.171 | Papain-like protease (SARS coronavirus) inhibitor | 0.142 0.042 DBMET00256 0.124 0.072 DBMET00257 0.158 0.027 DBMET01089 0.148 0.036 DBMET01090 0.126 0.068 DBMET01091 0.122 0.075 DBMET01128 0.171 0.019 DBMET01129 | DBMET01129 | |
| 0.094 | 0.067 | 0.345 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 DBMET00256 0.089 0.075 DBMET00257 0.195 0.019 DBMET01089 0.105 0.056 DBMET01090 0.098 0.063 DBMET01091 0.345 0.008 DBMET01128 0.21 0.017 DBMET01129 | DBMET01128 | |
| 0.044 | 0.017 | 0.044 | Delayed rectifier potassium channel blocker | |||
| 0.06 | 0.034 | 0.119 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.119 0.011 DBMET01089 0.087 0.018 DBMET01128 0.112 0.012 DBMET01129 | DBMET01089 | |
| 0.068 | 0.041 | 0.07 | Carbonic anhydrase inhibitor | 0.065 0.043 DBMET00256 0.06 0.046 DBMET00257 0.058 0.048 DBMET01090 0.07 0.04 DBMET01091 | DBMET01091 | |
| 0.045 | 0.018 | 0.076 | Diamine oxidase inhibitor | 0.034 0.031 DBMET00257 0.053 0.013 DBMET01089 0.076 0.005 DBMET01091 | DBMET01091 | |
| 0.189 | 0.164 | 0.388 | Prostaglandin dehydrogenase inhibitor | 0.188 0.165 DBMET00256 0.363 0.078 DBMET01089 0.34 0.086 DBMET01128 0.388 0.071 DBMET01129 | DBMET01129 | |
| 0.205 | 0.18 | 0.38 | Interleukin 2 agonist | 0.264 0.104 DBMET00256 0.204 0.182 DBMET00257 0.33 0.055 DBMET01089 0.263 0.105 DBMET01090 0.332 0.054 DBMET01091 0.344 0.048 DBMET01128 0.38 0.034 DBMET01129 | DBMET01129 | |
| 0.075 | 0.051 | 0.169 | Catalase inhibitor | 0.068 0.056 DBMET01089 0.068 0.056 DBMET01091 0.169 0.022 DBMET01128 0.079 0.048 DBMET01129 | DBMET01128 | |
| 0.143 | 0.121 | 0.353 | Phospholipase C inhibitor | 0.158 0.092 DBMET00256 0.145 0.117 DBMET00257 0.236 0.028 DBMET01089 0.159 0.089 DBMET01090 0.187 0.054 DBMET01091 0.298 0.018 DBMET01128 0.353 0.014 DBMET01129 | DBMET01129 | |
| 0.058 | 0.036 | 0.064 | Carbonic anhydrase II inhibitor | 0.055 0.039 DBMET00256 0.053 0.041 DBMET00257 0.05 0.044 DBMET01090 0.064 0.033 DBMET01091 | DBMET01091 | |
| 0.11 | 0.088 | 0.272 | M17 leucyl aminopeptidase inhibitor | 0.11 0.088 DBMET00256 0.113 0.085 DBMET00257 0.112 0.085 DBMET01090 0.114 0.084 DBMET01091 0.272 0.016 DBMET01128 0.12 0.077 DBMET01129 | DBMET01128 | |
| 0.102 | 0.081 | 0.102 | Calcium channel (voltage-sensitive) blocker | |||
| 0.095 | 0.075 | 0.369 | Carbonic anhydrase XV inhibitor | 0.106 0.06 DBMET00256 0.123 0.044 DBMET00257 0.299 0.008 DBMET01089 0.139 0.035 DBMET01090 0.174 0.024 DBMET01091 0.369 0.005 DBMET01128 0.366 0.005 DBMET01129 | DBMET01128 | |
| 0.05 | 0.03 | 0.119 | Glycine transporter 2 inhibitor | 0.041 0.038 DBMET00256 0.085 0.016 DBMET00257 0.071 0.02 DBMET01090 0.119 0.01 DBMET01091 0.05 0.031 DBMET01129 | DBMET01091 | |
| 0.125 | 0.106 | 0.132 | Thiol protease inhibitor | 0.128 0.101 DBMET01089 0.132 0.092 DBMET01128 | DBMET01128 | |
| 0.065 | 0.046 | 0.071 | Histone deacetylase inhibitor | 0.071 0.039 DBMET00257 0.06 0.054 DBMET01089 0.071 0.039 DBMET01091 | DBMET01091 | |
| 0.099 | 0.08 | 0.274 | GABA C receptor antagonist | 0.129 0.044 DBMET00257 0.268 0.005 DBMET01089 0.098 0.081 DBMET01090 0.175 0.019 DBMET01091 0.27 0.005 DBMET01128 0.274 0.005 DBMET01129 | DBMET01129 | |
| 0.07 | 0.052 | 0.09 | Phospholipase D inhibitor | 0.09 0.022 DBMET01089 0.07 0.052 DBMET01128 0.069 0.055 DBMET01129 | DBMET01089 | |
| 0.035 | 0.017 | 0.035 | GHS receptor antagonist | 0.033 0.021 DBMET01091 | ||
| 0.05 | 0.032 | 0.05 | CC chemokine receptor 2B antagonist | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | 0.047 0.04 DBMET01089 0.05 0.033 DBMET01129 | ||
| 0.18 | 0.163 | 0.222 | Transcription factor STAT3 inhibitor | 0.19 0.148 DBMET00256 0.181 0.162 DBMET00257 0.199 0.134 DBMET01089 0.191 0.146 DBMET01090 0.222 0.109 DBMET01091 0.208 0.124 DBMET01128 0.216 0.115 DBMET01129 | DBMET01091 | |
| 0.063 | 0.047 | 0.08 | Beta 3 adrenoreceptor antagonist | 0.066 0.04 DBMET00256 0.075 0.028 DBMET00257 0.08 0.024 DBMET01090 0.073 0.03 DBMET01129 | DBMET01090 | |
| 0.058 | 0.041 | 0.075 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DBMET00256 0.066 0.03 DBMET00257 0.073 0.023 DBMET01089 0.067 0.028 DBMET01090 0.071 0.024 DBMET01091 0.075 0.02 DBMET01129 | DBMET01129 | |
| 0.14 | 0.125 | 0.236 | Psychostimulant | 0.19 0.086 DBMET00257 0.232 0.065 DBMET01089 0.138 0.128 DBMET01091 0.143 0.123 DBMET01128 0.236 0.064 DBMET01129 | DBMET01129 | |
| 0.074 | 0.059 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.035 DBMET00257 0.073 0.064 DBMET01089 0.078 0.05 DBMET01091 0.072 0.066 DBMET01128 | DBMET00257 | |
| 0.044 | 0.029 | 0.057 | Histamine H1 receptor agonist | 0.057 0.01 DBMET00257 0.056 0.011 DBMET01089 0.056 0.011 DBMET01091 | DBMET00257 | |
| 0.06 | 0.045 | 0.152 | NMDA 2C receptor antagonist | 0.056 0.051 DBMET00257 0.127 0.009 DBMET01089 0.138 0.008 DBMET01091 0.134 0.008 DBMET01128 0.152 0.007 DBMET01129 | DBMET01129 | |
| 0.058 | 0.043 | 0.078 | Ryanodine receptor antagonist | 0.061 0.036 DBMET00256 0.072 0.015 DBMET01089 0.07 0.017 DBMET01128 0.078 0.01 DBMET01129 | DBMET01129 | |
| 0.03 | 0.016 | 0.048 | Estrogen-related receptor gamma antagonist | 0.035 0.009 DBMET00256 0.039 0.005 DBMET01089 0.029 0.019 DBMET01128 0.048 0.004 DBMET01129 | DBMET01129 | |
| 0.118 | 0.104 | 0.292 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.112 DBMET00256 0.262 0.01 DBMET01089 0.117 0.106 DBMET01091 0.292 0.006 DBMET01128 0.259 0.01 DBMET01129 | DBMET01128 | |
| 0.071 | 0.059 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.078 0.04 DBMET00257 0.08 0.035 DBMET01089 | DBMET01089 | |
| 0.07 | 0.057 | 0.31 | Glutamate dehydrogenase inhibitor | 0.138 0.018 DBMET01089 0.103 0.029 DBMET01091 0.31 0.005 DBMET01128 0.137 0.018 DBMET01129 | DBMET01128 | |
| 0.035 | 0.022 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.127 | 0.115 | 0.337 | Heat shock protein 90 alpha antagonist | 0.174 0.067 DBMET00256 0.168 0.071 DBMET00257 0.258 0.024 DBMET01089 0.221 0.038 DBMET01090 0.135 0.104 DBMET01091 0.239 0.031 DBMET01128 0.337 0.01 DBMET01129 | DBMET01129 | |
| 0.12 | 0.108 | 0.17 | Acetylcholine M1 receptor antagonist | 0.12 0.109 DBMET00257 0.17 0.058 DBMET01089 0.119 0.11 DBMET01128 0.158 0.067 DBMET01129 | DBMET01089 | |
| 0.125 | 0.114 | 0.148 | Pregnane X receptor agonist | 0.148 0.056 DBMET01089 0.137 0.081 DBMET01129 | DBMET01089 | |
| 0.056 | 0.045 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.015 DBMET00257 0.066 0.03 DBMET01089 0.062 0.035 DBMET01090 0.072 0.023 DBMET01091 0.062 0.036 DBMET01128 0.06 0.038 DBMET01129 | DBMET00257 | |
| 0.044 | 0.034 | 0.106 | Phosphorylase inhibitor | 0.072 0.019 DBMET00257 0.04 0.037 DBMET01089 0.058 0.026 DBMET01090 0.062 0.024 DBMET01091 0.106 0.012 DBMET01128 0.054 0.028 DBMET01129 | DBMET01128 | |
| 0.089 | 0.079 | 0.154 | Anabolic | 0.098 0.066 DBMET00256 0.132 0.029 DBMET01089 0.092 0.075 DBMET01090 0.088 0.082 DBMET01091 0.128 0.032 DBMET01128 0.154 0.016 DBMET01129 | DBMET01129 | |
| 0.126 | 0.116 | 0.149 | MAP kinase 3 inhibitor | 0.149 0.069 DBMET01089 0.127 0.115 DBMET01091 0.129 0.11 DBMET01129 | DBMET01089 | |
| 0.035 | 0.025 | 0.035 | Growth hormone secretagogue receptor antagonist | 0.031 0.028 DBMET01091 | ||
| 0.022 | 0.013 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.022 0.012 DBMET00257 0.02 0.016 DBMET01089 0.021 0.015 DBMET01091 0.029 0.005 DBMET01128 0.022 0.013 DBMET01129 | DBMET01128 | |
| 0.02 | 0.011 | 0.03 | Estrogen-related receptor gamma agonist | 0.026 0.005 DBMET00256 0.021 0.009 DBMET01089 0.02 0.01 DBMET01090 0.03 0.004 DBMET01129 | DBMET01129 | |
| 0.021 | 0.014 | 0.023 | Factor XIII inhibitor | 0.021 0.013 DBMET01089 0.023 0.01 DBMET01091 | DBMET01091 | |
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 DBMET01089 | ||
| 0.068 | 0.064 | 0.127 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.092 0.02 DBMET00257 0.127 0.005 DBMET01089 0.094 0.018 DBMET01091 0.099 0.014 DBMET01128 0.097 0.016 DBMET01129 | DBMET01089 | |
| 0.051 | 0.047 | 0.068 | Epithelial sodium channel blocker | 0.068 0.019 DBMET01089 0.065 0.022 DBMET01091 0.06 0.028 DBMET01129 | DBMET01089 | |
| 0.045 | 0.041 | 0.094 | Topoisomerase II beta inhibitor | 0.05 0.033 DBMET00256 0.06 0.022 DBMET01089 0.071 0.016 DBMET01128 0.094 0.01 DBMET01129 | DBMET01129 | |
| 0.024 | 0.02 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 DBMET01089 0.025 0.018 DBMET01128 | DBMET01128 | |
| 0.087 | 0.084 | 0.151 | Falcipain 3 inhibitor | 0.096 0.074 DBMET00257 0.143 0.04 DBMET01089 0.121 0.053 DBMET01091 0.151 0.036 DBMET01128 0.116 0.057 DBMET01129 | DBMET01128 | |
| 0.244 | 0.241 | 0.244 | MAP kinase 1 inhibitor | |||
| 0.069 | 0.067 | 0.085 | Vanilloid 4 agonist | 0.074 0.053 DBMET00257 0.085 0.033 DBMET01089 0.069 0.066 DBMET01091 0.069 0.067 DBMET01129 | DBMET01089 | |
| 0.116 | 0.114 | 0.116 | Cholinergic | |||
| 0.058 | 0.056 | 0.075 | Histone deacetylase SIRT3 inhibitor | 0.072 0.026 DBMET00257 0.064 0.038 DBMET01089 0.075 0.023 DBMET01091 0.063 0.042 DBMET01129 | DBMET01091 | |
| 0.033 | 0.031 | 0.033 | Factor XIIIa inhibitor | |||
| 0.118 | 0.117 | 0.306 | Heat shock protein 90 antagonist | 0.167 0.058 DBMET00256 0.162 0.063 DBMET00257 0.224 0.028 DBMET01089 0.225 0.028 DBMET01090 0.14 0.085 DBMET01091 0.171 0.054 DBMET01128 0.306 0.009 DBMET01129 | DBMET01129 | |
| 0.015 | 0.014 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.01 DBMET00256 | DBMET00256 | |
| 0.039 | 0.039 | 0.061 | Geranyltranstransferase inhibitor | 0.061 0.013 DBMET01089 0.054 0.019 DBMET01128 0.056 0.017 DBMET01129 | DBMET01089 | |
| 0.034 | 0.034 | 0.037 | Histone deacetylase class I inhibitor | 0.037 0.03 DBMET00257 0.036 0.031 DBMET01091 | DBMET00257 | |
| 0.111 | 0.112 | 0.156 | Vanilloid 1 agonist | 0.117 0.096 DBMET00256 0.117 0.096 DBMET00257 0.131 0.064 DBMET01089 0.122 0.082 DBMET01090 0.156 0.032 DBMET01091 0.151 0.037 DBMET01129 | DBMET01091 | |
| 0.044 | 0.045 | 0.061 | Bombesin 2 receptor antagonist | 0.061 0.024 DBMET00257 0.053 0.03 DBMET01090 0.048 0.036 DBMET01091 | DBMET00257 | |
| 0.08 | 0.082 | 0.378 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.197 0.016 DBMET01089 0.118 0.04 DBMET01091 0.378 0.004 DBMET01128 0.149 0.027 DBMET01129 | DBMET01128 | |
| 0.091 | 0.093 | 0.12 | Factor V inhibitor | 0.12 0.038 DBMET00257 0.104 0.06 DBMET01090 0.099 0.072 DBMET01091 0.097 0.077 DBMET01128 | DBMET00257 | |
| 0.035 | 0.037 | 0.055 | Oxytocin agonist | 0.039 0.033 DBMET00257 0.045 0.027 DBMET01089 0.039 0.033 DBMET01090 0.037 0.035 DBMET01091 0.055 0.021 DBMET01129 | DBMET01129 | |
| 0.036 | 0.039 | 0.048 | Thymidine kinase inhibitor | 0.048 0.02 DBMET01089 0.04 0.029 DBMET01129 | DBMET01089 | |
| 0.068 | 0.071 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.063 DBMET01091 | DBMET01091 | |
| 0.03 | 0.033 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.029 DBMET01128 | DBMET01128 | |
| 0.027 | 0.03 | 0.031 | Epoxide hydrolase 1 inhibitor | 0.028 0.026 DBMET00257 0.031 0.021 DBMET01089 | DBMET01089 | |
| 0.054 | 0.058 | 0.095 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.054 DBMET00256 0.07 0.028 DBMET01089 0.095 0.012 DBMET01129 | DBMET01129 | |
| 0.049 | 0.053 | 0.057 | DNA helicase inhibitor | 0.053 0.041 DBMET00256 0.057 0.034 DBMET01128 | DBMET01128 | |
| 0.081 | 0.085 | 0.265 | Creatine kinase inhibitor | 0.104 0.055 DBMET00256 0.18 0.014 DBMET01089 0.098 0.061 DBMET01090 0.114 0.046 DBMET01091 0.265 0.005 DBMET01128 0.26 0.005 DBMET01129 | DBMET01128 | |
| 0.025 | 0.03 | 0.037 | Purinergic P2Y15 antagonist | 0.03 0.018 DBMET00257 0.037 0.009 DBMET01089 0.032 0.014 DBMET01091 0.036 0.009 DBMET01129 | DBMET01089 | |
| 0.077 | 0.082 | 0.104 | Hematopoietic | 0.079 0.075 DBMET00257 0.08 0.074 DBMET01090 0.104 0.032 DBMET01091 | DBMET01091 | |
| 0.076 | 0.081 | 0.154 | D-Ala-D-Ala ligase inhibitor | 0.093 0.039 DBMET00256 0.136 0.008 DBMET01089 0.093 0.039 DBMET01090 0.094 0.038 DBMET01091 0.152 0.005 DBMET01128 0.154 0.005 DBMET01129 | DBMET01129 | |
| 0.054 | 0.062 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.073 0.024 DBMET01089 0.065 0.036 DBMET01091 | DBMET01089 | |
| 0.024 | 0.031 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET01089 | DBMET01089 | |
| 0.041 | 0.049 | 0.11 | Potassium channel (Inward rectifier) blocker | 0.11 0.005 DBMET01089 0.048 0.037 DBMET01128 0.069 0.018 DBMET01129 | DBMET01089 | |
| 0.057 | 0.065 | 0.076 | Beta 2 adrenoreceptor agonist | 0.07 0.019 DBMET00256 0.062 0.042 DBMET00257 0.059 0.053 DBMET01089 0.076 0.012 DBMET01090 0.059 0.053 DBMET01091 0.07 0.02 DBMET01129 | DBMET01090 | |
| 0.103 | 0.112 | 0.18 | Alkaline phosphatase inhibitor | 0.115 0.093 DBMET00256 0.13 0.076 DBMET01089 0.147 0.062 DBMET01128 0.18 0.042 DBMET01129 | DBMET01129 | |
| 0.073 | 0.082 | 0.087 | Histamine H2 receptor antagonist | 0.08 0.066 DBMET00257 0.087 0.051 DBMET01089 | DBMET01089 | |
| 0.023 | 0.033 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.022 DBMET00257 0.026 0.021 DBMET01091 | DBMET01091 | |
| 0.032 | 0.043 | 0.053 | Potassium channel Kv1.1 blocker | 0.035 0.034 DBMET00257 0.053 0.011 DBMET01089 0.037 0.029 DBMET01129 | DBMET01089 | |
| 0.029 | 0.039 | 0.051 | Bombesin 1 receptor antagonist | 0.044 0.018 DBMET00257 0.051 0.013 DBMET01091 | DBMET01091 | |
| 0.118 | 0.129 | 0.223 | Adenylate cyclase stimulant | 0.132 0.098 DBMET00256 0.147 0.067 DBMET00257 0.188 0.02 DBMET01089 0.159 0.048 DBMET01090 0.158 0.05 DBMET01091 0.162 0.045 DBMET01128 0.223 0.006 DBMET01129 | DBMET01129 | |
| 0.032 | 0.043 | 0.052 | Membrane dipeptidase inhibitor | 0.043 0.023 DBMET01089 0.036 0.034 DBMET01091 0.052 0.014 DBMET01128 | DBMET01128 | |
| 0.005 | 0.015 | 0.012 | DNA topoisomerase III inhibitor | 0.012 0.003 DBMET01089 0.008 0.004 DBMET01129 | DBMET01089 | |
| 0.027 | 0.038 | 0.055 | Phosphoglycerate kinase inhibitor | 0.045 0.016 DBMET01089 0.055 0.012 DBMET01128 0.055 0.012 DBMET01129 | DBMET01129 | |
| 0.193 | 0.206 | 0.225 | Ca(v)3.3 blocker | 0.209 0.172 DBMET00257 0.225 0.142 DBMET01091 | DBMET01091 | |
| 0.067 | 0.081 | 0.088 | Bcr-Abl kinase inhibitor | 0.088 0.054 DBMET01089 0.084 0.06 DBMET01129 | DBMET01089 | |
| 0.14 | 0.154 | 0.357 | Neurotrophic factor enhancer | 0.173 0.106 DBMET00256 0.286 0.022 DBMET01089 0.17 0.11 DBMET01090 0.174 0.105 DBMET01091 0.239 0.045 DBMET01128 0.357 0.008 DBMET01129 | DBMET01129 | |
| 0.171 | 0.185 | 0.22 | Transcription factor STAT inhibitor | 0.176 0.175 DBMET00256 0.2 0.138 DBMET01089 0.22 0.112 DBMET01091 0.195 0.146 DBMET01128 0.215 0.118 DBMET01129 | DBMET01091 | |
| 0.045 | 0.061 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.042 DBMET01089 | DBMET01089 | |
| 0.033 | 0.049 | 0.071 | Histamine H2 receptor agonist | 0.046 0.025 DBMET00257 0.071 0.01 DBMET01089 0.071 0.01 DBMET01091 | DBMET01091 | |
| 0.049 | 0.066 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.071 0.01 DBMET01089 0.058 0.028 DBMET01091 0.057 0.032 DBMET01128 0.06 0.024 DBMET01129 | DBMET01089 | |
| 0.032 | 0.05 | 0.134 | NMDA receptor subunit 3B antagonist | 0.054 0.022 DBMET01089 0.058 0.02 DBMET01091 0.134 0.008 DBMET01128 0.096 0.011 DBMET01129 | DBMET01128 | |
| 0.098 | 0.116 | 0.161 | Toll-Like receptor 9 antagonist | 0.161 0.056 DBMET01089 0.109 0.098 DBMET01129 | DBMET01089 | |
| 0.064 | 0.082 | 0.139 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.139 0.017 DBMET01089 0.121 0.025 DBMET01129 | DBMET01089 | |
| 0.016 | 0.034 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 DBMET01089 | DBMET01089 | |
| 0.038 | 0.057 | 0.052 | Bombesin antagonist | 0.052 0.026 DBMET00257 0.044 0.04 DBMET01090 0.049 0.031 DBMET01091 | DBMET00257 | |
| 0.015 | 0.034 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET01089 0.021 0.007 DBMET01128 0.018 0.014 DBMET01129 | DBMET01128 | |
| 0.034 | 0.054 | 0.231 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.099 0.003 DBMET01089 0.039 0.035 DBMET01090 0.046 0.021 DBMET01091 0.231 0.001 DBMET01128 0.136 0.002 DBMET01129 | DBMET01128 | |
| 0.045 | 0.066 | 0.086 | Androgen agonist | 0.068 0.032 DBMET01089 0.086 0.021 DBMET01129 | DBMET01129 | |
| 0.042 | 0.063 | 0.062 | Alpha-mannosidase inhibitor | 0.061 0.025 DBMET01089 0.053 0.037 DBMET01128 0.062 0.025 DBMET01129 | DBMET01129 | |
| 0.118 | 0.139 | 0.244 | LIM domain kinase 1 inhibitor | 0.244 0.041 DBMET01089 0.142 0.106 DBMET01091 0.166 0.083 DBMET01128 0.218 0.055 DBMET01129 | DBMET01089 | |
| 0.093 | 0.115 | 0.165 | Interleukin 8 antagonist | 0.146 0.036 DBMET01089 0.14 0.041 DBMET01091 0.118 0.065 DBMET01128 0.165 0.026 DBMET01129 | DBMET01129 | |
| 0.09 | 0.111 | 0.145 | Microtubule formation inhibitor | 0.139 0.044 DBMET01089 0.12 0.061 DBMET01128 0.145 0.04 DBMET01129 | DBMET01129 | |
| 0.023 | 0.046 | 0.036 | 5-Alpha-reductase inhibitor | 0.036 0.027 DBMET01128 | DBMET01128 | |
| 0.028 | 0.051 | 0.083 | Dihydropteroate synthase inhibitor | 0.039 0.029 DBMET00257 0.071 0.008 DBMET01089 0.041 0.026 DBMET01090 0.039 0.029 DBMET01091 0.083 0.006 DBMET01128 0.081 0.006 DBMET01129 | DBMET01128 | |
| 0.117 | 0.141 | 0.28 | Interferon gamma antagonist | 0.131 0.108 DBMET00256 0.189 0.045 DBMET01089 0.134 0.103 DBMET01090 0.28 0.023 DBMET01128 0.256 0.027 DBMET01129 | DBMET01128 | |
| 0.038 | 0.062 | 0.28 | H+/K+-transporting ATPase inhibitor | 0.28 0.004 DBMET01089 0.075 0.015 DBMET01128 0.157 0.005 DBMET01129 | DBMET01089 | |
| 0.067 | 0.091 | 0.141 | Myeloperoxidase inhibitor | 0.083 0.06 DBMET00257 0.121 0.019 DBMET01089 0.087 0.054 DBMET01090 0.083 0.062 DBMET01091 0.115 0.022 DBMET01128 0.141 0.013 DBMET01129 | DBMET01129 | |
| 0.009 | 0.033 | 0.021 | NMDA receptor phencyclidine site antagonist | 0.021 0.007 DBMET01089 0.021 0.006 DBMET01129 | DBMET01129 | |
| 0.02 | 0.045 | 0.029 | Acid ceramidase inhibitor | 0.029 0.011 DBMET01089 | DBMET01089 | |
| 0.059 | 0.084 | 0.165 | Glycine receptor agonist | 0.128 0.01 DBMET01089 0.093 0.025 DBMET01091 0.165 0.005 DBMET01128 0.142 0.008 DBMET01129 | DBMET01128 | |
| 0.12 | 0.145 | 0.24 | CF transmembrane conductance regulator agonist | 0.135 0.105 DBMET00256 0.208 0.018 DBMET01089 0.132 0.114 DBMET01090 0.16 0.059 DBMET01091 0.165 0.052 DBMET01128 0.24 0.008 DBMET01129 | DBMET01129 | |
| 0.088 | 0.114 | 0.104 | Caspase 3 inhibitor | 0.104 0.085 DBMET00257 0.104 0.086 DBMET01090 0.103 0.087 DBMET01128 | DBMET01090 | |
| 0.033 | 0.059 | 0.067 | AICAR transformylase inhibitor | 0.061 0.013 DBMET01089 0.067 0.011 DBMET01128 0.059 0.014 DBMET01129 | DBMET01128 | |
| 0.009 | 0.035 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET01089 0.017 0.011 DBMET01091 0.017 0.011 DBMET01128 | DBMET01128 | |
| 0.009 | 0.035 | 0.017 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET01089 0.017 0.011 DBMET01091 0.017 0.011 DBMET01128 | DBMET01128 | |
| 0.046 | 0.072 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.044 DBMET00257 | DBMET00257 | |
| 0.018 | 0.044 | 0.036 | Glutamate (mGluR1) agonist | 0.029 0.011 DBMET01089 0.036 0.006 DBMET01128 0.027 0.013 DBMET01129 | DBMET01128 | |
| 0.025 | 0.052 | 0.034 | Opioid delta receptor agonist | 0.034 0.026 DBMET01129 | DBMET01129 | |
| 0.024 | 0.05 | 0.049 | TRPM8 blocker | 0.049 0.016 DBMET01128 | DBMET01128 | |
| 0.026 | 0.053 | 0.041 | Histone deacetylase 8 inhibitor | 0.041 0.029 DBMET01091 | DBMET01091 | |
| 0.047 | 0.074 | 0.114 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET00256 0.06 0.029 DBMET01090 0.053 0.045 DBMET01091 0.114 0.004 DBMET01128 0.068 0.017 DBMET01129 | DBMET01128 | |
| 0.095 | 0.123 | 0.629 | Lipid peroxidase inhibitor | 0.179 0.051 DBMET00256 0.58 0.004 DBMET01089 0.165 0.059 DBMET01090 0.466 0.006 DBMET01128 0.629 0.004 DBMET01129 | DBMET01129 | |
| 0.084 | 0.112 | 0.104 | Acetylcholine muscarinic antagonist | 0.104 0.085 DBMET01089 0.099 0.092 DBMET01129 | DBMET01089 | |
| 0.034 | 0.062 | 0.087 | Adenylate cyclase 1 inhibitor | 0.047 0.031 DBMET00257 0.087 0.005 DBMET01089 0.055 0.022 DBMET01091 0.085 0.006 DBMET01129 | DBMET01089 | |
| 0.03 | 0.059 | 0.107 | NMDA 2A receptor antagonist | 0.072 0.023 DBMET01089 0.049 0.038 DBMET01091 0.107 0.012 DBMET01128 0.089 0.016 DBMET01129 | DBMET01128 | |
| 0.048 | 0.077 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | 0.074 0.022 DBMET01089 0.065 0.033 DBMET01128 | DBMET01089 | |
| 0.023 | 0.053 | 0.121 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET01089 0.037 0.028 DBMET01091 0.121 0.007 DBMET01128 0.086 0.01 DBMET01129 | DBMET01128 | |
| 0.044 | 0.075 | 0.054 | 5 Hydroxytryptamine 7 agonist | 0.054 0.044 DBMET01089 | DBMET01089 | |
| 0.032 | 0.062 | 0.061 | Nerve growth factor antagonist | 0.057 0.011 DBMET01089 0.061 0.009 DBMET01128 0.041 0.033 DBMET01129 | DBMET01128 | |
| 0.037 | 0.068 | 0.641 | Alcohol oxidase inhibitor | 0.146 0.011 DBMET01089 0.104 0.017 DBMET01091 0.641 0.003 DBMET01128 0.288 0.005 DBMET01129 | DBMET01128 | |
| 0.108 | 0.139 | 0.147 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.083 DBMET01089 0.124 0.111 DBMET01091 | DBMET01089 | |
| 0.012 | 0.044 | 0.038 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.038 0.013 DBMET01089 0.027 0.02 DBMET01128 0.028 0.019 DBMET01129 | DBMET01089 | |
| 0.165 | 0.197 | 0.274 | Hypoxia-inducible factor 1 alpha inhibitor | 0.195 0.158 DBMET00256 0.205 0.146 DBMET01089 0.207 0.143 DBMET01128 0.274 0.08 DBMET01129 | DBMET01129 | |
| 0.063 | 0.095 | 0.077 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.077 0.076 DBMET01089 | DBMET01089 | |
| 0.013 | 0.045 | 0.057 | Glutamate (mGluR1a) agonist | 0.057 0.004 DBMET01089 0.028 0.01 DBMET01091 0.048 0.005 DBMET01128 0.042 0.005 DBMET01129 | DBMET01089 | |
| 0.025 | 0.057 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET00257 | DBMET00257 | |
| 0.017 | 0.049 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.028 0.017 DBMET01089 0.049 0.004 DBMET01128 | DBMET01128 | |
| 0.015 | 0.048 | 0.024 | Prostaglandin EP4 antagonist | 0.024 0.021 DBMET01128 | DBMET01128 | |
| 0.094 | 0.128 | 0.13 | Transcription factor STAT6 inhibitor | 0.13 0.044 DBMET01089 0.12 0.06 DBMET01091 0.128 0.047 DBMET01129 | DBMET01089 | |
| 0.019 | 0.053 | 0.027 | Myristoyl transferase inhibitor | 0.025 0.024 DBMET01089 0.027 0.02 DBMET01091 | DBMET01091 | |
| 0.01 | 0.045 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 DBMET01089 | DBMET01089 | |
| 0.052 | 0.087 | 0.076 | Cathepsin G inhibitor | 0.076 0.047 DBMET01089 0.073 0.05 DBMET01128 0.066 0.058 DBMET01129 | DBMET01089 | |
| 0.127 | 0.162 | 0.171 | Death-associated protein kinase 3 inhibitor | 0.14 0.139 DBMET01089 0.141 0.138 DBMET01091 0.171 0.095 DBMET01128 | DBMET01128 | |
| 0.029 | 0.065 | 0.062 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 DBMET01089 0.062 0.033 DBMET01129 | DBMET01129 | |
| 0.029 | 0.066 | 0.064 | Ribonucleotide reductase inhibitor | 0.046 0.045 DBMET01089 0.064 0.034 DBMET01129 | DBMET01129 | |
| 0.108 | 0.146 | 0.233 | Dual specificity phosphatase 3 inhibitor | 0.17 0.08 DBMET00256 0.141 0.105 DBMET01090 0.233 0.046 DBMET01128 0.176 0.076 DBMET01129 | DBMET01128 | |
| 0.014 | 0.052 | 0.032 | Retinoid X beta receptor antagonist | 0.022 0.01 DBMET01089 0.032 0.004 DBMET01128 | DBMET01128 | |
| 0.072 | 0.11 | 0.181 | Expectorant | 0.101 0.067 DBMET00257 0.133 0.043 DBMET01089 0.119 0.051 DBMET01090 0.099 0.07 DBMET01091 0.181 0.025 DBMET01128 0.174 0.027 DBMET01129 | DBMET01128 | |
| 0.017 | 0.055 | 0.033 | Thyroid hormone agonist | 0.025 0.019 DBMET00256 0.025 0.02 DBMET01090 0.033 0.01 DBMET01129 | DBMET01129 | |
| 0.028 | 0.066 | 0.065 | AMPA 4 receptor antagonist | 0.044 0.02 DBMET01089 0.065 0.009 DBMET01128 0.045 0.02 DBMET01129 | DBMET01128 | |
| 0.167 | 0.205 | 0.399 | Transcription factor NF kappa B inhibitor | 0.226 0.146 DBMET00256 0.271 0.113 DBMET01089 0.205 0.164 DBMET01090 0.206 0.163 DBMET01091 0.299 0.095 DBMET01128 0.399 0.064 DBMET01129 | DBMET01129 | |
| 0.066 | 0.104 | 0.117 | MAP kinase kinase 7 inhibitor | 0.1 0.013 DBMET01089 0.084 0.036 DBMET01091 0.094 0.019 DBMET01128 0.117 0.005 DBMET01129 | DBMET01129 | |
| 0.012 | 0.051 | 0.025 | Antibiotic Anthracycline-like | 0.022 0.008 DBMET01089 0.018 0.016 DBMET01128 0.025 0.005 DBMET01129 | DBMET01129 | |
| 0.038 | 0.077 | 0.065 | Cytokine production stimulant | 0.065 0.009 DBMET01089 0.051 0.027 DBMET01129 | DBMET01089 | |
| 0.158 | 0.197 | 0.369 | 12-Lipoxygenase inhibitor | 0.23 0.122 DBMET00256 0.25 0.109 DBMET01089 0.23 0.122 DBMET01090 0.24 0.115 DBMET01128 0.369 0.049 DBMET01129 | DBMET01129 | |
| 0.014 | 0.054 | 0.022 | Toll-Like receptor 8 agonist | 0.022 0.01 DBMET01089 | DBMET01089 | |
| 0.053 | 0.093 | 0.159 | CYP2A6 inhibitor | 0.159 0.014 DBMET01089 0.092 0.04 DBMET01091 0.108 0.032 DBMET01129 | DBMET01089 | |
| 0.054 | 0.094 | 0.166 | Glutamate (mGluR6) antagonist | 0.117 0.006 DBMET01089 0.072 0.035 DBMET01091 0.166 0.003 DBMET01128 0.102 0.01 DBMET01129 | DBMET01128 | |
| 0.047 | 0.087 | 0.065 | Leukotriene C antagonist | 0.065 0.019 DBMET01128 0.054 0.048 DBMET01129 | DBMET01128 | |
| 0.017 | 0.057 | 0.039 | Vanilloid 2 agonist | 0.031 0.009 DBMET01089 0.032 0.007 DBMET01128 0.039 0.004 DBMET01129 | DBMET01129 | |
| 0.011 | 0.052 | 0.034 | Imidazoline I1 receptor antagonist | 0.034 0.005 DBMET01089 0.021 0.013 DBMET01091 | DBMET01089 | |
| 0.019 | 0.06 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET01089 | DBMET01089 | |
| 0.033 | 0.076 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.029 DBMET01089 0.051 0.033 DBMET01091 0.066 0.017 DBMET01128 0.045 0.044 DBMET01129 | DBMET01128 | |
| 0.034 | 0.077 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.015 DBMET01089 0.062 0.017 DBMET01128 0.069 0.013 DBMET01129 | DBMET01129 | |
| 0.029 | 0.073 | 0.102 | Dihydroorotase inhibitor | 0.043 0.033 DBMET01089 0.102 0.005 DBMET01128 | DBMET01128 | |
| 0.009 | 0.053 | 0.027 | Alpha 2c adrenoreceptor agonist | 0.027 0.005 DBMET01089 | DBMET01089 | |
| 0.079 | 0.123 | 0.323 | Amylase inhibitor | 0.121 0.081 DBMET00256 0.218 0.038 DBMET01089 0.211 0.04 DBMET01128 0.323 0.015 DBMET01129 | DBMET01129 | |
| 0.042 | 0.086 | 0.139 | Carbonic anhydrase V inhibitor | 0.072 0.041 DBMET00257 0.104 0.026 DBMET01089 0.064 0.049 DBMET01090 0.081 0.035 DBMET01091 0.127 0.02 DBMET01128 0.139 0.017 DBMET01129 | DBMET01129 | |
| 0.028 | 0.073 | 0.05 | Mannosidase inhibitor | 0.05 0.025 DBMET01089 0.05 0.025 DBMET01128 0.049 0.027 DBMET01129 | DBMET01128 | |
| 0.056 | 0.101 | 0.116 | Androgen antagonist | 0.087 0.058 DBMET01089 0.116 0.035 DBMET01129 | DBMET01129 | |
| 0.009 | 0.054 | 0.037 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 DBMET01089 0.037 0.004 DBMET01128 0.021 0.008 DBMET01129 | DBMET01128 | |
| 0.057 | 0.103 | 0.281 | Carbonic anhydrase VI inhibitor | 0.087 0.049 DBMET00257 0.166 0.018 DBMET01089 0.086 0.05 DBMET01090 0.102 0.038 DBMET01091 0.245 0.009 DBMET01128 0.281 0.007 DBMET01129 | DBMET01129 | |
| 0.065 | 0.112 | 0.178 | Alcohol dehydrogenase inhibitor | 0.116 0.037 DBMET01089 0.178 0.015 DBMET01128 0.157 0.018 DBMET01129 | DBMET01128 | |
| 0.014 | 0.06 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.016 DBMET01091 | DBMET01091 | |
| 0.097 | 0.144 | 0.25 | Diuretic | 0.147 0.08 DBMET01089 0.132 0.092 DBMET01091 0.25 0.031 DBMET01128 0.131 0.093 DBMET01129 | DBMET01128 | |
| 0.069 | 0.116 | 0.144 | Granulocyte macrophage colony stimulating factor agonist | 0.144 0.006 DBMET01089 0.08 0.075 DBMET01091 0.127 0.012 DBMET01128 0.131 0.01 DBMET01129 | DBMET01089 | |
| 0.12 | 0.168 | 0.234 | 3C-like protease (Human coronavirus) inhibitor | 0.143 0.114 DBMET00257 0.234 0.035 DBMET01089 0.152 0.097 DBMET01091 0.203 0.05 DBMET01128 0.179 0.066 DBMET01129 | DBMET01089 | |
| 0.022 | 0.07 | 0.065 | Alpha 1d adrenoreceptor agonist | 0.065 0.009 DBMET01089 0.044 0.022 DBMET01091 0.059 0.011 DBMET01129 | DBMET01089 | |
| 0.035 | 0.084 | 0.117 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.037 DBMET00256 0.067 0.023 DBMET01089 0.062 0.028 DBMET01128 0.117 0.008 DBMET01129 | DBMET01129 | |
| 0.071 | 0.12 | 0.145 | Nitric-oxide synthase inhibitor | 0.145 0.025 DBMET01089 0.096 0.067 DBMET01091 0.11 0.046 DBMET01129 | DBMET01089 | |
| 0.07 | 0.12 | 0.145 | MAP kinase kinase 1 inhibitor | 0.143 0.019 DBMET01089 0.145 0.019 DBMET01128 0.133 0.025 DBMET01129 | DBMET01128 | |
| 0.009 | 0.059 | 0.022 | Dopamine autoreceptor agonist | 0.022 0.018 DBMET01089 | DBMET01089 | |
| 0.011 | 0.061 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 DBMET01089 | DBMET01089 | |
| 0.012 | 0.063 | 0.052 | Arginase inhibitor | 0.035 0.027 DBMET01089 0.036 0.026 DBMET01091 0.052 0.014 DBMET01128 0.039 0.023 DBMET01129 | DBMET01128 | |
| 0.03 | 0.081 | 0.043 | Leukotriene C4 antagonist | 0.043 0.018 DBMET01128 | DBMET01128 | |
| 0.008 | 0.059 | 0.026 | Alpha 2a adrenoreceptor agonist | 0.026 0.006 DBMET01089 0.022 0.008 DBMET01129 | DBMET01089 | |
| 0.013 | 0.065 | 0.027 | Lysine carboxypeptidase inhibitor | 0.024 0.022 DBMET01089 0.027 0.019 DBMET01128 0.024 0.023 DBMET01129 | DBMET01128 | |
| 0.02 | 0.072 | 0.027 | Glucosylceramidase stimulant | 0.027 0.019 DBMET01089 | DBMET01089 | |
| 0.017 | 0.069 | 0.084 | Fumarate hydratase inhibitor | 0.047 0.014 DBMET01089 0.084 0.007 DBMET01128 0.045 0.015 DBMET01129 | DBMET01128 | |
| 0.044 | 0.096 | 0.059 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 DBMET01089 | DBMET01089 | |
| 0.042 | 0.094 | 0.059 | Neuronal nicotinic receptor antagonist | 0.059 0.055 DBMET01091 | DBMET01091 | |
| 0.004 | 0.057 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 DBMET01089 | DBMET01089 | |
| 0.017 | 0.07 | 0.028 | Thrombin receptor antagonist | 0.028 0.02 DBMET01091 | DBMET01091 | |
| 0.037 | 0.09 | 0.064 | Acetylcholine M5 receptor antagonist | 0.064 0.037 DBMET01089 | DBMET01089 | |
| 0.029 | 0.082 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.064 0.01 DBMET01128 | DBMET01128 | |
| 0.07 | 0.123 | 0.112 | Alpha 2b adrenoreceptor antagonist | 0.112 0.065 DBMET01089 | DBMET01089 | |
| 0.071 | 0.124 | 0.207 | 5 Hydroxytryptamine 3A agonist | 0.207 0.013 DBMET01089 0.161 0.03 DBMET01091 0.19 0.018 DBMET01129 | DBMET01089 | |
| 0.01 | 0.064 | 0.04 | NMDA receptor glycine site antagonist | 0.021 0.02 DBMET01089 0.04 0.008 DBMET01128 0.023 0.019 DBMET01129 | DBMET01128 | |
| 0.15 | 0.204 | 0.367 | DNA synthesis inhibitor | 0.193 0.134 DBMET00256 0.231 0.082 DBMET00257 0.296 0.045 DBMET01089 0.276 0.053 DBMET01090 0.2 0.123 DBMET01091 0.367 0.027 DBMET01128 0.332 0.034 DBMET01129 | DBMET01128 | |
| 0.018 | 0.072 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.024 DBMET01089 | DBMET01089 | |
| 0.037 | 0.092 | 0.06 | Heparanase inhibitor | 0.049 0.047 DBMET01089 0.06 0.024 DBMET01128 | DBMET01128 | |
| 0.028 | 0.084 | 0.038 | Vanilloid 3 antagonist | 0.038 0.026 DBMET01089 | DBMET01089 | |
| 0.045 | 0.101 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.055 DBMET00257 0.072 0.035 DBMET01089 0.06 0.052 DBMET01091 | DBMET01089 | |
| 0.032 | 0.088 | 0.25 | Argininosuccinate synthase inhibitor | 0.125 0.014 DBMET01089 0.052 0.044 DBMET01091 0.25 0.005 DBMET01128 0.114 0.016 DBMET01129 | DBMET01128 | |
| 0.014 | 0.071 | 0.05 | Kainate receptor 2 antagonist | 0.05 0.016 DBMET01128 | DBMET01128 | |
| 0.021 | 0.08 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.028 DBMET01128 | DBMET01128 | |
| 0.073 | 0.131 | 0.124 | Cholesterol synthesis inhibitor | 0.114 0.07 DBMET01128 0.124 0.061 DBMET01129 | DBMET01129 | |
| 0.01 | 0.069 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.011 DBMET01089 | DBMET01089 | |
| 0.059 | 0.118 | 0.125 | GABA B receptor agonist | 0.097 0.018 DBMET01089 0.099 0.017 DBMET01091 0.104 0.014 DBMET01128 0.125 0.006 DBMET01129 | DBMET01129 | |
| 0.073 | 0.132 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.079 DBMET01089 | DBMET01089 | |
| 0.027 | 0.087 | 0.083 | Dihydrofolate reductase inhibitor | 0.083 0.004 DBMET01089 0.067 0.007 DBMET01128 0.072 0.006 DBMET01129 | DBMET01089 | |
| 0.017 | 0.077 | 0.125 | Retinoid X alpha receptor agonist | 0.05 0.014 DBMET01089 0.125 0.004 DBMET01128 0.04 0.02 DBMET01129 | DBMET01128 | |
| 0.036 | 0.096 | 0.141 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.062 0.037 DBMET01089 0.141 0.008 DBMET01128 0.109 0.014 DBMET01129 | DBMET01128 | |
| 0.048 | 0.108 | 0.107 | Glutamate (mGluR7) antagonist | 0.107 0.008 DBMET01089 0.066 0.051 DBMET01091 0.102 0.01 DBMET01128 0.093 0.015 DBMET01129 | DBMET01089 | |
| 0.025 | 0.087 | 0.099 | Glutamate (mGluR8) agonist | 0.071 0.005 DBMET01089 0.037 0.028 DBMET01091 0.099 0.003 DBMET01128 0.071 0.005 DBMET01129 | DBMET01128 | |
| 0.08 | 0.141 | 0.195 | Photosensitizer | 0.165 0.023 DBMET01089 0.116 0.062 DBMET01091 0.195 0.014 DBMET01128 0.179 0.018 DBMET01129 | DBMET01128 | |
| 0.106 | 0.168 | 0.199 | Dual specificity phosphatase inhibitor | 0.153 0.091 DBMET00256 0.13 0.12 DBMET01090 0.199 0.055 DBMET01128 0.159 0.085 DBMET01129 | DBMET01128 | |
| 0.02 | 0.081 | 0.041 | Angiotensin II receptor antagonist | 0.041 0.013 DBMET01128 | DBMET01128 | |
| 0.022 | 0.084 | 0.053 | Angiotensin AT1 receptor antagonist | 0.053 0.013 DBMET01128 | DBMET01128 | |
| 0.024 | 0.087 | 0.13 | Ornithine carbamoyltransferase inhibitor | 0.067 0.027 DBMET01089 0.057 0.034 DBMET01091 0.13 0.011 DBMET01128 0.059 0.032 DBMET01129 | DBMET01128 | |
| 0.007 | 0.069 | 0.02 | Cyclin T1 inhibitor | 0.02 0.011 DBMET01089 | DBMET01089 | |
| 0.01 | 0.073 | 0.058 | Retinoid X gamma receptor agonist | 0.058 0.005 DBMET01128 | DBMET01128 | |
| 0.021 | 0.084 | 0.126 | Dopamine D5 agonist | 0.07 0.008 DBMET01089 0.042 0.025 DBMET01091 0.039 0.03 DBMET01128 0.126 0.003 DBMET01129 | DBMET01129 | |
| 0.017 | 0.08 | 0.04 | Farnesoid X receptor agonist | 0.04 0.023 DBMET01128 | DBMET01128 | |
| 0.039 | 0.102 | 0.053 | 5 Hydroxytryptamine 5 antagonist | 0.053 0.05 DBMET01089 | DBMET01089 | |
| 0.033 | 0.096 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.06 0.016 DBMET01089 0.046 0.041 DBMET01091 0.047 0.037 DBMET01128 0.067 0.009 DBMET01129 | DBMET01129 | |
| 0.01 | 0.074 | 0.049 | Uridine phosphorylase inhibitor | 0.035 0.014 DBMET01089 0.049 0.009 DBMET01128 0.032 0.016 DBMET01129 | DBMET01128 | |
| 0.082 | 0.146 | 0.125 | Sodium channel blocker | 0.125 0.078 DBMET01089 | DBMET01089 | |
| 0.041 | 0.106 | 0.068 | Beta adrenoreceptor antagonist | 0.066 0.044 DBMET01090 0.068 0.042 DBMET01129 | DBMET01129 | |
| 0.037 | 0.102 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | 0.123 0.015 DBMET01089 0.098 0.026 DBMET01128 0.103 0.024 DBMET01129 | DBMET01089 | |
| 0.039 | 0.105 | 0.186 | Purinergic P2X1 antagonist | 0.131 0.009 DBMET01089 0.186 0.004 DBMET01128 0.147 0.007 DBMET01129 | DBMET01128 | |
| 0.071 | 0.137 | 0.139 | Beta glucuronidase inhibitor | 0.091 0.085 DBMET00256 0.102 0.067 DBMET01089 0.108 0.059 DBMET01128 0.139 0.031 DBMET01129 | DBMET01129 | |
| 0.052 | 0.119 | 0.201 | Potassium channel (Ca-activated) activator | 0.087 0.067 DBMET00256 0.15 0.028 DBMET01089 0.201 0.014 DBMET01128 0.172 0.021 DBMET01129 | DBMET01128 | |
| 0.088 | 0.156 | 0.108 | Antibacterial (Helicobacter pylori) | 0.108 0.102 DBMET01089 0.108 0.102 DBMET01129 | DBMET01129 | |
| 0.014 | 0.082 | 0.026 | Calcium-sensing receptor agonist | 0.026 0.02 DBMET01128 | DBMET01128 | |
| 0.021 | 0.089 | 0.049 | Retinoid X alpha receptor antagonist | 0.034 0.023 DBMET01089 0.049 0.007 DBMET01128 | DBMET01128 | |
| 0.039 | 0.108 | 0.125 | Carbonic anhydrase VA inhibitor | 0.102 0.024 DBMET01089 0.07 0.047 DBMET01091 0.115 0.019 DBMET01128 0.125 0.017 DBMET01129 | DBMET01129 | |
| 0.035 | 0.104 | 0.095 | Alpha 2 adrenoreceptor agonist | 0.095 0.016 DBMET01089 0.08 0.023 DBMET01129 | DBMET01089 | |
| 0.036 | 0.106 | 0.054 | Vanilloid 2 antagonist | 0.054 0.031 DBMET01129 | DBMET01129 | |
| 0.013 | 0.082 | 0.104 | Retinoid X receptor agonist | 0.05 0.018 DBMET01089 0.104 0.004 DBMET01128 0.038 0.024 DBMET01129 | DBMET01128 | |
| 0.022 | 0.092 | 0.136 | Carbonic anhydrase VB inhibitor | 0.106 0.015 DBMET01089 0.059 0.036 DBMET01091 0.131 0.011 DBMET01128 0.136 0.01 DBMET01129 | DBMET01129 | |
| 0.051 | 0.121 | 0.086 | Calcium channel P-type blocker | 0.086 0.011 DBMET01089 0.064 0.042 DBMET01128 0.071 0.025 DBMET01129 | DBMET01089 | |
| 0.017 | 0.087 | 0.036 | Complement factor 1s inhibitor | 0.036 0.004 DBMET01089 0.024 0.022 DBMET01091 0.024 0.021 DBMET01128 0.026 0.016 DBMET01129 | DBMET01089 | |
| 0.042 | 0.113 | 0.236 | Glutamate decarboxylase inhibitor | 0.112 0.024 DBMET01089 0.091 0.035 DBMET01091 0.236 0.005 DBMET01128 0.183 0.008 DBMET01129 | DBMET01128 | |
| 0.019 | 0.09 | 0.028 | Hedgehog signaling activator | 0.028 0.016 DBMET01089 0.027 0.021 DBMET01129 | DBMET01089 | |
| 0.023 | 0.094 | 0.069 | Thymidylate synthase inhibitor | 0.062 0.016 DBMET01089 0.069 0.012 DBMET01128 0.056 0.02 DBMET01129 | DBMET01128 | |
| 0.127 | 0.198 | 0.215 | Histone acetyltransferase inhibitor | 0.212 0.052 DBMET01089 0.193 0.081 DBMET01128 0.215 0.049 DBMET01129 | DBMET01129 | |
| 0.022 | 0.094 | 0.061 | Glutamate (mGluR1a) antagonist | 0.061 0.014 DBMET01089 0.038 0.032 DBMET01128 | DBMET01089 | |
| 0.003 | 0.075 | 0.011 | Progesterone receptor A antagonist | 0.011 0.005 DBMET01089 0.01 0.005 DBMET01129 | DBMET01089 | |
| 0.044 | 0.116 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.033 DBMET01089 0.068 0.065 DBMET01129 | DBMET01089 | |
| 0.018 | 0.09 | 0.033 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.03 DBMET01089 | DBMET01089 | |
| 0.01 | 0.083 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET01128 | DBMET01128 | |
| 0.031 | 0.104 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 DBMET01089 | DBMET01089 | |
| 0.032 | 0.106 | 0.054 | Potassium channel (Inward rectifier) activator | 0.054 0.029 DBMET01089 | DBMET01089 | |
| 0.023 | 0.097 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.037 DBMET01128 | DBMET01128 | |
| 0.062 | 0.136 | 0.165 | Protein kinase (CK2) alpha inhibitor | 0.095 0.081 DBMET01089 0.091 0.086 DBMET01091 0.165 0.034 DBMET01128 0.104 0.073 DBMET01129 | DBMET01128 | |
| 0.063 | 0.138 | 0.082 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET01091 | DBMET01091 | |
| 0.03 | 0.105 | 0.186 | Aconitate hydratase inhibitor | 0.093 0.01 DBMET01089 0.047 0.043 DBMET01091 0.186 0.003 DBMET01128 0.07 0.019 DBMET01129 | DBMET01128 | |
| 0.023 | 0.098 | 0.057 | Retinoid X receptor antagonist | 0.038 0.026 DBMET01089 0.057 0.008 DBMET01128 | DBMET01128 | |
| 0.049 | 0.124 | 0.074 | Adenosine A3 receptor antagonist | 0.074 0.052 DBMET01089 | DBMET01089 | |
| 0.004 | 0.08 | 0.012 | Angiotensin AT1B receptor antagonist | 0.012 0.011 DBMET01128 | DBMET01128 | |
| 0.04 | 0.117 | 0.068 | Pregnane X receptor antagonist | 0.065 0.02 DBMET01089 0.065 0.02 DBMET01128 0.068 0.016 DBMET01129 | DBMET01129 | |
| 0.022 | 0.099 | 0.036 | MAP3K5 inhibitor | 0.036 0.032 DBMET01089 | DBMET01089 | |
| 0.051 | 0.128 | 0.157 | Keratolytic | 0.073 0.06 DBMET00257 0.089 0.038 DBMET01089 0.095 0.034 DBMET01090 0.069 0.067 DBMET01091 0.157 0.013 DBMET01128 0.142 0.016 DBMET01129 | DBMET01128 | |
| 0.034 | 0.111 | 0.067 | Cyclin D1 inhibitor | 0.067 0.032 DBMET01089 0.062 0.039 DBMET01129 | DBMET01089 | |
| 0.031 | 0.108 | 0.121 | Carbamoyl phosphate synthetase inhibitor | 0.115 0.017 DBMET01089 0.105 0.019 DBMET01128 0.121 0.015 DBMET01129 | DBMET01129 | |
| 0.049 | 0.127 | 0.092 | Exportin-1 inhibitor | 0.092 0.014 DBMET01089 0.065 0.057 DBMET01091 0.073 0.038 DBMET01129 | DBMET01089 | |
| 0.013 | 0.093 | 0.101 | Nicotinic acid receptor agonist | 0.101 0.005 DBMET01128 0.032 0.031 DBMET01129 | DBMET01128 | |
| 0.01 | 0.09 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.015 DBMET01128 | DBMET01128 | |
| 0.016 | 0.096 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET01089 0.025 0.022 DBMET01129 | DBMET01089 | |
| 0.02 | 0.1 | 0.06 | Glutamate (mGluR3) agonist | 0.041 0.009 DBMET01089 0.06 0.004 DBMET01128 0.051 0.005 DBMET01129 | DBMET01128 | |
| 0.031 | 0.112 | 0.124 | NMDA 2 receptor antagonist | 0.091 0.037 DBMET01089 0.093 0.036 DBMET01091 0.102 0.031 DBMET01128 0.124 0.023 DBMET01129 | DBMET01129 | |
| 0.046 | 0.127 | 0.131 | Ornithine decarboxylase inhibitor | 0.1 0.044 DBMET01089 0.081 0.066 DBMET01090 0.077 0.071 DBMET01091 0.131 0.019 DBMET01128 0.108 0.035 DBMET01129 | DBMET01128 | |
| 0.063 | 0.144 | 0.439 | Cystathionine beta-synthase inhibitor | 0.105 0.071 DBMET00256 0.263 0.013 DBMET01089 0.095 0.083 DBMET01090 0.093 0.086 DBMET01091 0.314 0.009 DBMET01128 0.439 0.004 DBMET01129 | DBMET01129 | |
| 0.107 | 0.187 | 0.253 | I kappa B kinase epsilon inhibitor | 0.215 0.059 DBMET01089 0.253 0.036 DBMET01128 0.204 0.068 DBMET01129 | DBMET01128 | |
| 0.023 | 0.104 | 0.114 | Dihydroorotate dehydrogenase inhibitor | 0.114 0.008 DBMET01128 | DBMET01128 | |
| 0.007 | 0.088 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 DBMET01129 | DBMET01129 | |
| 0.049 | 0.13 | 0.14 | NMDA receptor antagonist | 0.078 0.068 DBMET01089 0.106 0.043 DBMET01091 0.14 0.028 DBMET01128 0.112 0.039 DBMET01129 | DBMET01128 | |
| 0.007 | 0.09 | 0.019 | Telomerase stimulant | 0.017 0.012 DBMET01089 0.019 0.008 DBMET01129 | DBMET01129 | |
| 0.119 | 0.203 | 0.158 | Catenin beta inhibitor | 0.153 0.1 DBMET00256 0.158 0.089 DBMET01128 0.156 0.093 DBMET01129 | DBMET01128 | |
| 0.067 | 0.15 | 0.206 | Toll-Like receptor 3 antagonist | 0.206 0.005 DBMET01089 0.125 0.026 DBMET01091 0.099 0.052 DBMET01129 | DBMET01089 | |
| 0.01 | 0.095 | 0.058 | Endothelial nitric-oxide synthase inhibitor | 0.058 0.008 DBMET01089 | DBMET01089 | |
| 0.062 | 0.146 | 0.129 | Lanosterol 14 alpha demethylase inhibitor | 0.129 0.023 DBMET01089 0.111 0.04 DBMET01129 | DBMET01089 | |
| 0.145 | 0.231 | 0.458 | Cholesterol antagonist | 0.32 0.079 DBMET01089 0.458 0.039 DBMET01128 0.384 0.053 DBMET01129 | DBMET01128 | |
| 0.027 | 0.112 | 0.058 | Kainate receptor agonist | 0.05 0.014 DBMET01089 0.058 0.008 DBMET01128 0.047 0.018 DBMET01129 | DBMET01128 | |
| 0.009 | 0.095 | 0.041 | Acetylcholine M4 receptor agonist | 0.041 0.015 DBMET01089 | DBMET01089 | |
| 0.019 | 0.105 | 0.072 | GABA uptake inhibitor | 0.044 0.021 DBMET01089 0.072 0.006 DBMET01128 | DBMET01128 | |
| 0.077 | 0.163 | 0.24 | NADPH oxidase inhibitor | 0.163 0.047 DBMET01089 0.209 0.032 DBMET01128 0.24 0.023 DBMET01129 | DBMET01129 | |
| 0.056 | 0.144 | 0.096 | Caspase 7 inhibitor | 0.096 0.033 DBMET01089 0.079 0.063 DBMET01129 | DBMET01089 | |
| 0.063 | 0.151 | 0.161 | Adenylate cyclase inhibitor | 0.132 0.058 DBMET01089 0.104 0.081 DBMET01091 0.161 0.038 DBMET01128 0.156 0.041 DBMET01129 | DBMET01128 | |
| 0.019 | 0.108 | 0.069 | Adenosine deaminase inhibitor | 0.062 0.019 DBMET01089 0.069 0.014 DBMET01128 0.059 0.022 DBMET01129 | DBMET01128 | |
| 0.073 | 0.163 | 0.12 | Cytokine production inhibitor | 0.12 0.09 DBMET01089 0.115 0.095 DBMET01091 | DBMET01089 | |
| 0.028 | 0.119 | 0.075 | Acetylcholine M5 receptor agonist | 0.075 0.039 DBMET01089 | DBMET01089 | |
| 0.045 | 0.136 | 0.063 | Heme oxygenase stimulant | 0.059 0.049 DBMET00257 0.063 0.039 DBMET01090 0.058 0.051 DBMET01128 0.062 0.042 DBMET01129 | DBMET01090 | |
| 0.039 | 0.13 | 0.174 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.115 0.031 DBMET01089 0.153 0.018 DBMET01128 0.174 0.013 DBMET01129 | DBMET01129 | |
| 0.082 | 0.173 | 0.249 | Protein kinase stimulant | 0.178 0.051 DBMET01089 0.149 0.069 DBMET01091 0.216 0.036 DBMET01128 0.249 0.027 DBMET01129 | DBMET01129 | |
| 0.003 | 0.095 | 0.028 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET01089 0.028 0.003 DBMET01128 0.019 0.004 DBMET01129 | DBMET01128 | |
| 0.164 | 0.258 | 0.322 | MAP kinase kinase 3 inhibitor | 0.2 0.121 DBMET00257 0.322 0.005 DBMET01089 0.224 0.067 DBMET01091 0.246 0.036 DBMET01128 0.252 0.03 DBMET01129 | DBMET01089 | |
| 0.02 | 0.115 | 0.076 | Fructose-1,6-bisphosphatase inhibitor | 0.076 0.009 DBMET01089 0.067 0.013 DBMET01128 0.07 0.012 DBMET01129 | DBMET01089 | |
| 0.057 | 0.152 | 0.107 | MAO inhibitor | 0.107 0.084 DBMET01129 | DBMET01129 | |
| 0.033 | 0.128 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET01089 | DBMET01089 | |
| 0.089 | 0.184 | 0.227 | Arachidonic acid antagonist | 0.219 0.018 DBMET01089 0.227 0.013 DBMET01128 0.227 0.013 DBMET01129 | DBMET01129 | |
| 0.01 | 0.106 | 0.035 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.015 DBMET01089 | DBMET01089 | |
| 0.032 | 0.129 | 0.061 | Fatty acid synthase inhibitor | 0.061 0.034 DBMET01129 | DBMET01129 | |
| 0.031 | 0.128 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.028 DBMET01090 0.045 0.034 DBMET01129 | DBMET01090 | |
| 0.035 | 0.132 | 0.233 | Carbonic anhydrase XIII inhibitor | 0.137 0.025 DBMET01089 0.066 0.063 DBMET01091 0.233 0.01 DBMET01128 0.217 0.012 DBMET01129 | DBMET01128 | |
| 0.031 | 0.128 | 0.068 | CDC7 inhibitor | 0.068 0.047 DBMET01089 | DBMET01089 | |
| 0.026 | 0.124 | 0.045 | Potassium channel small-conductance Ca-activated blocker | 0.045 0.03 DBMET01089 | DBMET01089 | |
| 0.085 | 0.183 | 0.218 | Phospholipase A2 inhibitor | 0.128 0.104 DBMET01089 0.218 0.034 DBMET01128 0.14 0.085 DBMET01129 | DBMET01128 | |
| 0.023 | 0.122 | 0.054 | Opioid delta receptor antagonist | 0.054 0.051 DBMET01129 | DBMET01129 | |
| 0.076 | 0.175 | 0.142 | Activin receptor-like kinase 2 inhibitor | 0.142 0.074 DBMET01089 0.117 0.1 DBMET01129 | DBMET01089 | |
| 0.043 | 0.142 | 0.105 | MAO A inhibitor | 0.105 0.061 DBMET01129 | DBMET01129 | |
| 0.058 | 0.159 | 0.237 | Protein-tyrosine kinase Lyn inhibitor | 0.237 0.033 DBMET01089 0.12 0.085 DBMET01129 | DBMET01089 | |
| 0.058 | 0.16 | 0.112 | Bromodomain-containing protein 2 inhibitor | 0.112 0.029 DBMET01089 0.086 0.064 DBMET01129 | DBMET01089 | |
| 0.017 | 0.119 | 0.068 | Guanylate cyclase inhibitor | 0.063 0.009 DBMET01089 0.068 0.005 DBMET01128 0.057 0.014 DBMET01129 | DBMET01128 | |
| 0.043 | 0.146 | 0.105 | Somatostatin 1 agonist | 0.105 0.031 DBMET01091 0.069 0.066 DBMET01129 | DBMET01091 | |
| 0.087 | 0.191 | 0.332 | Hexokinase inhibitor | 0.122 0.116 DBMET00256 0.211 0.029 DBMET01089 0.127 0.108 DBMET01091 0.332 0.008 DBMET01128 0.242 0.019 DBMET01129 | DBMET01128 | |
| 0.007 | 0.111 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.011 DBMET01089 0.016 0.01 DBMET01129 | DBMET01129 | |
| 0.045 | 0.149 | 0.101 | Transcription factor RelA inhibitor | 0.096 0.008 DBMET01089 0.069 0.032 DBMET01128 0.101 0.006 DBMET01129 | DBMET01129 | |
| 0.034 | 0.139 | 0.105 | Neuraminidase (influenza) inhibitor | 0.105 0.015 DBMET01128 0.061 0.051 DBMET01129 | DBMET01128 | |
| 0.089 | 0.194 | 0.409 | Aryl hydrocarbon receptor agonist | 0.403 0.037 DBMET01089 0.175 0.117 DBMET01091 0.35 0.048 DBMET01128 0.409 0.036 DBMET01129 | DBMET01129 | |
| 0.022 | 0.129 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.045 0.017 DBMET01089 | DBMET01089 | |
| 0.029 | 0.136 | 0.066 | Prostaglandin-E synthase inhibitor | 0.066 0.054 DBMET01128 | DBMET01128 | |
| 0.021 | 0.13 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.042 0.032 DBMET01091 | DBMET01091 | |
| 0.026 | 0.135 | 0.132 | Glutamate (mGluR4) antagonist | 0.085 0.007 DBMET01089 0.132 0.004 DBMET01128 0.052 0.019 DBMET01129 | DBMET01128 | |
| 0.003 | 0.113 | 0.012 | Thrombopoietin agonist | 0.012 0.007 DBMET01128 | DBMET01128 | |
| 0.004 | 0.114 | 0.04 | AMPA 1 receptor antagonist | 0.04 0.015 DBMET01128 | DBMET01128 | |
| 0.081 | 0.191 | 0.209 | Cell wall synthesis inhibitor | 0.147 0.069 DBMET01089 0.148 0.067 DBMET01091 0.209 0.027 DBMET01128 0.166 0.051 DBMET01129 | DBMET01128 | |
| 0.026 | 0.138 | 0.221 | Phosphofructokinase-1 inhibitor | 0.13 0.022 DBMET01089 0.221 0.009 DBMET01128 0.149 0.018 DBMET01129 | DBMET01128 | |
| 0.031 | 0.144 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 DBMET01089 0.043 0.028 DBMET01129 | DBMET01089 | |
| 0.031 | 0.144 | 0.362 | Histidine decarboxylase inhibitor | 0.156 0.018 DBMET01089 0.084 0.04 DBMET01091 0.362 0.004 DBMET01128 0.302 0.006 DBMET01129 | DBMET01128 | |
| 0.031 | 0.148 | 0.064 | CD45 antagonist | 0.048 0.04 DBMET01089 0.064 0.018 DBMET01128 0.048 0.039 DBMET01129 | DBMET01128 | |
| 0.01 | 0.129 | 0.165 | Kainate receptor antagonist | 0.048 0.023 DBMET01089 0.165 0.004 DBMET01128 0.043 0.027 DBMET01129 | DBMET01128 | |
| 0.008 | 0.127 | 0.026 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.023 DBMET01089 | DBMET01089 | |
| 0.031 | 0.15 | 0.076 | Acetylcholine M4 receptor antagonist | 0.076 0.05 DBMET01089 | DBMET01089 | |
| 0.021 | 0.143 | 0.05 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.038 DBMET01089 | DBMET01089 | |
| 0.036 | 0.158 | 0.082 | Aryl hydrocarbon receptor antagonist | 0.082 0.025 DBMET01089 0.078 0.028 DBMET01129 | DBMET01089 | |
| 0.018 | 0.141 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 DBMET01089 0.083 0.016 DBMET01128 0.078 0.017 DBMET01129 | DBMET01128 | |
| 0.041 | 0.164 | 0.108 | Adrenaline agonist | 0.073 0.067 DBMET00256 0.108 0.032 DBMET01090 0.095 0.04 DBMET01129 | DBMET01090 | |
| 0.003 | 0.126 | 0.037 | Kainate receptor 1 antagonist | 0.037 0.008 DBMET01128 | DBMET01128 | |
| 0.013 | 0.136 | 0.044 | Peroxisome proliferator-activated receptor alpha agonist | 0.044 0.037 DBMET01128 | DBMET01128 | |
| 0.024 | 0.148 | 0.068 | 5 Hydroxytryptamine 2A agonist | 0.068 0.039 DBMET01089 0.068 0.039 DBMET01129 | DBMET01129 | |
| 0.024 | 0.147 | 0.054 | Histamine agonist | 0.054 0.035 DBMET01089 | DBMET01089 | |
| 0.006 | 0.13 | 0.049 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.049 0.007 DBMET01129 | DBMET01129 | |
| 0.014 | 0.138 | 0.046 | Glutamate (mGluR group I) agonist | 0.046 0.035 DBMET01089 | DBMET01089 | |
| 0.046 | 0.171 | 0.125 | Mediator release inhibitor | 0.125 0.043 DBMET01128 0.098 0.072 DBMET01129 | DBMET01128 | |
| 0.054 | 0.179 | 0.117 | Bile acid receptor antagonist | 0.103 0.043 DBMET01089 0.116 0.024 DBMET01128 0.117 0.023 DBMET01129 | DBMET01129 | |
| 0.007 | 0.133 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.033 0.006 DBMET01089 0.027 0.01 DBMET01128 0.03 0.008 DBMET01129 | DBMET01089 | |
| 0.031 | 0.157 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.09 0.041 DBMET01089 0.071 0.059 DBMET01128 0.102 0.03 DBMET01129 | DBMET01129 | |
| 0.011 | 0.138 | 0.049 | Carbonic anhydrase VII inhibitor | 0.049 0.029 DBMET01128 0.048 0.03 DBMET01129 | DBMET01128 | |
| 0.063 | 0.19 | 0.11 | Sodium channel (voltage-gated) blocker | 0.11 0.096 DBMET01089 | DBMET01089 | |
| 0.042 | 0.17 | 0.079 | Opioid antagonist | 0.076 0.075 DBMET01090 0.079 0.07 DBMET01129 | DBMET01129 | |
| 0.128 | 0.257 | 0.182 | MAP kinase kinase 5 inhibitor | 0.182 0.058 DBMET01089 | DBMET01089 | |
| 0.022 | 0.151 | 0.053 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 DBMET01129 | DBMET01129 | |
| 0.012 | 0.141 | 0.03 | Integrin alpha2beta1 antagonist | 0.026 0.019 DBMET01089 0.03 0.012 DBMET01128 | DBMET01128 | |
| 0.018 | 0.149 | 0.045 | Glutamate (mGluR5) agonist | 0.045 0.033 DBMET01089 | DBMET01089 | |
| 0.03 | 0.161 | 0.072 | Protein kinase C beta inhibitor | 0.064 0.061 DBMET01089 0.072 0.043 DBMET01129 | DBMET01129 | |
| 0.009 | 0.142 | 0.048 | Potassium channel small-conductance Ca-activated activator | 0.048 0.011 DBMET01089 | DBMET01089 | |
| 0.011 | 0.144 | 0.035 | NMDA 2D receptor antagonist | 0.035 0.012 DBMET01128 | DBMET01128 | |
| 0.058 | 0.192 | 0.104 | Protein kinase (CK1) gamma 2 inhibitor | 0.104 0.079 DBMET01089 | DBMET01089 | |
| 0.025 | 0.159 | 0.05 | Myc inhibitor | 0.05 0.045 DBMET00257 | DBMET00257 | |
| 0.01 | 0.146 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 DBMET01128 | DBMET01128 | |
| 0.089 | 0.224 | 0.204 | Melanin inhibitor | 0.147 0.086 DBMET01089 0.127 0.121 DBMET01090 0.134 0.106 DBMET01128 0.204 0.039 DBMET01129 | DBMET01129 | |
| 0.013 | 0.148 | 0.073 | Nicotinic receptor beta4 subunit antagonist | 0.073 0.009 DBMET01091 | DBMET01091 | |
| 0.032 | 0.168 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.046 DBMET01089 | DBMET01089 | |
| 0.037 | 0.173 | 0.085 | Secretase beta inhibitor | 0.085 0.03 DBMET01089 0.07 0.049 DBMET01129 | DBMET01089 | |
| 0.046 | 0.183 | 0.22 | HIV-1 integrase (Overall Integration) inhibitor | 0.206 0.01 DBMET01089 0.085 0.072 DBMET01091 0.22 0.008 DBMET01128 0.218 0.008 DBMET01129 | DBMET01128 | |
| 0.037 | 0.174 | 0.151 | Protein kinase (CK2) inhibitor | 0.151 0.032 DBMET01128 0.082 0.081 DBMET01129 | DBMET01128 | |
| 0.021 | 0.16 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.053 0.032 DBMET01129 | DBMET01129 | |
| 0.017 | 0.156 | 0.042 | Glutamate (mGluR4) agonist | 0.04 0.015 DBMET01089 0.042 0.014 DBMET01128 0.034 0.023 DBMET01129 | DBMET01128 | |
| 0.021 | 0.16 | 0.061 | Diacylglycerol O-acyltransferase inhibitor | 0.061 0.025 DBMET01128 | DBMET01128 | |
| 0.017 | 0.157 | 0.044 | Sphingosine 1-phosphate receptor agonist | 0.044 0.032 DBMET01128 | DBMET01128 | |
| 0.019 | 0.159 | 0.057 | Toll-Like receptor 8 antagonist | 0.057 0.034 DBMET01089 | DBMET01089 | |
| 0.016 | 0.157 | 0.041 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET01089 0.041 0.015 DBMET01128 0.031 0.028 DBMET01129 | DBMET01128 | |
| 0.019 | 0.16 | 0.099 | Neuraminidase inhibitor | 0.099 0.016 DBMET01128 | DBMET01128 | |
| 0.082 | 0.225 | 0.141 | DNA repair enzyme inhibitor | 0.141 0.041 DBMET01089 0.119 0.074 DBMET01128 0.139 0.043 DBMET01129 | DBMET01089 | |
| 0.057 | 0.199 | 0.085 | Vanilloid agonist | 0.085 0.057 DBMET01129 | DBMET01129 | |
| 0.036 | 0.179 | 0.228 | Monophenol monooxygenase inhibitor | 0.112 0.067 DBMET01089 0.146 0.049 DBMET01128 0.228 0.027 DBMET01129 | DBMET01129 | |
| 0.024 | 0.168 | 0.054 | Leukotriene B4 antagonist | 0.054 0.036 DBMET01128 | DBMET01128 | |
| 0.062 | 0.206 | 0.218 | DOPA decarboxylase inhibitor | 0.151 0.021 DBMET01089 0.181 0.01 DBMET01128 0.218 0.005 DBMET01129 | DBMET01129 | |
| 0.017 | 0.161 | 0.042 | Integrin alpha2 antagonist | 0.036 0.026 DBMET01089 0.042 0.018 DBMET01128 | DBMET01128 | |
| 0.048 | 0.194 | 0.086 | Insulin receptor antagonist | 0.086 0.084 DBMET01089 | DBMET01089 | |
| 0.025 | 0.171 | 0.05 | Histamine H4 receptor antagonist | 0.05 0.031 DBMET01089 | DBMET01089 | |
| 0.008 | 0.156 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.03 0.025 DBMET01129 | DBMET01129 | |
| 0.02 | 0.168 | 0.074 | Glutamate (mGluR group III) agonist | 0.062 0.018 DBMET01089 0.074 0.014 DBMET01128 0.048 0.025 DBMET01129 | DBMET01128 | |
| 0.018 | 0.167 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.034 DBMET01129 | DBMET01129 | |
| 0.006 | 0.155 | 0.044 | Retinoid X beta receptor agonist | 0.044 0.005 DBMET01128 | DBMET01128 | |
| 0.02 | 0.17 | 0.054 | Cyclin A1 inhibitor | 0.054 0.052 DBMET01089 | DBMET01089 | |
| 0.047 | 0.198 | 0.074 | MDM2 inhibitor | 0.073 0.031 DBMET01089 0.074 0.029 DBMET01128 0.066 0.052 DBMET01129 | DBMET01128 | |
| 0.025 | 0.177 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET01129 | DBMET01129 | |
| 0.092 | 0.244 | 0.353 | Free radical scavenger | 0.22 0.083 DBMET00256 0.244 0.071 DBMET01090 0.353 0.038 DBMET01129 | DBMET01129 | |
| 0.055 | 0.208 | 0.14 | Interleukin 1b antagonist | 0.14 0.047 DBMET01089 | DBMET01089 | |
| 0.046 | 0.2 | 0.099 | Estrogen receptor alpha antagonist | 0.099 0.028 DBMET01129 | DBMET01129 | |
| 0.023 | 0.178 | 0.06 | 5 Hydroxytryptamine 3A antagonist | 0.06 0.056 DBMET01089 | DBMET01089 | |
| 0.087 | 0.242 | 0.201 | Tumour necrosis factor antagonist | 0.201 0.053 DBMET01089 0.155 0.094 DBMET01128 0.197 0.055 DBMET01129 | DBMET01089 | |
| 0.019 | 0.175 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.016 DBMET01091 | DBMET01091 | |
| 0.024 | 0.183 | 0.148 | Glutamate (mGluR group III) antagonist | 0.092 0.006 DBMET01089 0.148 0.004 DBMET01128 0.06 0.013 DBMET01129 | DBMET01128 | |
| 0.011 | 0.171 | 0.054 | Purinergic P2Y antagonist | 0.054 0.023 DBMET01128 | DBMET01128 | |
| 0.017 | 0.178 | 0.043 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET01089 0.043 0.01 DBMET01128 | DBMET01128 | |
| 0.007 | 0.169 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET01089 | DBMET01089 | |
| 0.01 | 0.174 | 0.111 | AMPA receptor antagonist | 0.064 0.023 DBMET01089 0.111 0.01 DBMET01128 0.05 0.031 DBMET01129 | DBMET01128 | |
| 0.089 | 0.253 | 0.184 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.111 DBMET01089 0.184 0.029 DBMET01128 0.133 0.11 DBMET01129 | DBMET01128 | |
| 0.069 | 0.235 | 0.333 | Pyruvate kinase inhibitor | 0.228 0.068 DBMET01089 0.189 0.088 DBMET01128 0.333 0.039 DBMET01129 | DBMET01129 | |
| 0.011 | 0.178 | 0.038 | ATP citrate lysase inhibitor | 0.035 0.017 DBMET01128 0.038 0.014 DBMET01129 | DBMET01129 | |
| 0.05 | 0.218 | 0.111 | mTOR complex 2 inhibitor | 0.111 0.023 DBMET01089 0.079 0.071 DBMET01128 0.101 0.032 DBMET01129 | DBMET01089 | |
| 0.028 | 0.197 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.092 0.019 DBMET01089 0.073 0.033 DBMET01129 | DBMET01089 | |
| 0.008 | 0.177 | 0.034 | Free fatty acid receptor 1 antagonist | 0.031 0.028 DBMET01089 0.034 0.023 DBMET01128 | DBMET01128 | |
| 0.008 | 0.177 | 0.049 | Vascular adhesion protein 1 inhibitor | 0.044 0.02 DBMET01089 0.049 0.016 DBMET01091 | DBMET01091 | |
| 0.051 | 0.222 | 0.152 | Beta amyloid protein antagonist | 0.151 0.04 DBMET01089 0.152 0.039 DBMET01129 | DBMET01129 | |
| 0.034 | 0.205 | 0.073 | I kappa B kinase inhibitor | 0.073 0.072 DBMET01089 | DBMET01089 | |
| 0.029 | 0.199 | 0.089 | Topoisomerase II alpha inhibitor | 0.089 0.047 DBMET01129 | DBMET01129 | |
| 0.025 | 0.197 | 0.069 | Sphingosine kinase inhibitor | 0.06 0.04 DBMET01089 0.069 0.026 DBMET01129 | DBMET01129 | |
| 0.053 | 0.226 | 0.125 | Protein kinase (CK1) gamma inhibitor | 0.125 0.085 DBMET01089 | DBMET01089 | |
| 0.037 | 0.211 | 0.092 | Pim-3 kinase inhibitor | 0.092 0.055 DBMET01089 | DBMET01089 | |
| 0.009 | 0.184 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET01129 | DBMET01129 | |
| 0.123 | 0.298 | 0.295 | Antithrombotic | 0.245 0.13 DBMET01089 0.295 0.092 DBMET01128 0.276 0.106 DBMET01129 | DBMET01128 | |
| 0.085 | 0.26 | 0.332 | Non-steroidal antiinflammatory agent | 0.233 0.05 DBMET01089 0.332 0.022 DBMET01128 0.239 0.048 DBMET01129 | DBMET01128 | |
| 0.023 | 0.199 | 0.07 | Alpha adrenoreceptor agonist | 0.07 0.045 DBMET01089 0.061 0.054 DBMET01129 | DBMET01089 | |
| 0.057 | 0.234 | 0.14 | Interleukin 12 antagonist | 0.107 0.044 DBMET01089 0.14 0.016 DBMET01129 | DBMET01129 | |
| 0.039 | 0.216 | 0.089 | GABA A receptor agonist | 0.089 0.05 DBMET01089 | DBMET01089 | |
| 0.005 | 0.184 | 0.055 | Kainate receptor 5 antagonist | 0.055 0.005 DBMET01128 | DBMET01128 | |
| 0.02 | 0.2 | 0.064 | Leukotriene antagonist | 0.064 0.046 DBMET01128 | DBMET01128 | |
| 0.006 | 0.187 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET01129 | DBMET01129 | |
| 0.039 | 0.222 | 0.119 | Topoisomerase II inhibitor | 0.094 0.092 DBMET00256 0.115 0.071 DBMET01090 0.119 0.068 DBMET01129 | DBMET01129 | |
| 0.036 | 0.219 | 0.113 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.113 0.075 DBMET01089 | DBMET01089 | |
| 0.036 | 0.219 | 0.112 | Abl kinase inhibitor | 0.112 0.075 DBMET01089 | DBMET01089 | |
| 0.01 | 0.197 | 0.029 | CDK4/cyclin D3 inhibitor | 0.029 0.019 DBMET01089 | DBMET01089 | |
| 0.033 | 0.22 | 0.097 | Potassium channel large-conductance Ca-activated activator | 0.063 0.055 DBMET00256 0.097 0.025 DBMET01128 0.073 0.041 DBMET01129 | DBMET01128 | |
| 0.017 | 0.208 | 0.122 | Nicotinic acid receptor 1 agonist | 0.122 0.005 DBMET01128 | DBMET01128 | |
| 0.116 | 0.308 | 0.269 | Immunosuppressant | 0.269 0.135 DBMET01128 | DBMET01128 | |
| 0.009 | 0.204 | 0.036 | Catechol O-methyltransferase inhibitor | 0.036 0.018 DBMET01129 | DBMET01129 | |
| 0.055 | 0.251 | 0.184 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.184 0.09 DBMET01089 0.176 0.096 DBMET01128 0.174 0.097 DBMET01129 | DBMET01089 | |
| 0.075 | 0.271 | 0.199 | Growth hormone agonist | 0.153 0.085 DBMET01090 0.199 0.059 DBMET01091 | DBMET01091 | |
| 0.016 | 0.214 | 0.03 | ATR kinase inhibitor | 0.03 0.029 DBMET01089 | DBMET01089 | |
| 0.045 | 0.245 | 0.145 | MAP kinase kinase inhibitor | 0.139 0.058 DBMET01089 0.145 0.054 DBMET01128 0.145 0.054 DBMET01129 | DBMET01129 | |
| 0.023 | 0.223 | 0.065 | Alpha 1L adrenoreceptor agonist | 0.065 0.006 DBMET00256 0.064 0.007 DBMET01090 | DBMET00256 | |
| 0.036 | 0.236 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | 0.088 0.024 DBMET01128 | DBMET01128 | |
| 0.058 | 0.26 | 0.151 | Protein kinase (CK1) gamma 1 inhibitor | 0.151 0.068 DBMET01089 0.119 0.099 DBMET01128 | DBMET01089 | |
| 0.007 | 0.21 | 0.029 | Retinoic acid beta receptor agonist | 0.029 0.005 DBMET01128 | DBMET01128 | |
| 0.047 | 0.252 | 0.127 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.127 0.108 DBMET01089 | DBMET01089 | |
| 0.033 | 0.241 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.052 DBMET01089 | DBMET01089 | |
| 0.008 | 0.216 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET01128 | DBMET01128 | |
| 0.021 | 0.23 | 0.05 | Thromboxane synthase inhibitor | 0.05 0.049 DBMET01128 | DBMET01128 | |
| 0.013 | 0.222 | 0.039 | Growth hormone release inhibitor | 0.039 0.032 DBMET01091 | DBMET01091 | |
| 0.01 | 0.219 | 0.065 | Glutamate (mGluR1) antagonist | 0.065 0.035 DBMET01089 0.057 0.041 DBMET01128 | DBMET01089 | |
| 0.007 | 0.216 | 0.067 | Estradiol 17 beta-dehydrogenase inhibitor | 0.067 0.017 DBMET01129 | DBMET01129 | |
| 0.021 | 0.232 | 0.048 | Aldosterone antagonist | 0.048 0.032 DBMET01089 | DBMET01089 | |
| 0.005 | 0.217 | 0.046 | Kynurenine 3 monooxygenase inhibitor | 0.046 0.008 DBMET01128 | DBMET01128 | |
| 0.028 | 0.24 | 0.287 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.093 DBMET00256 0.129 0.064 DBMET01089 0.121 0.07 DBMET01090 0.114 0.076 DBMET01128 0.287 0.014 DBMET01129 | DBMET01129 | |
| 0.012 | 0.224 | 0.037 | RNA-directed RNA polymerase inhibitor | 0.037 0.021 DBMET01128 | DBMET01128 | |
| 0.013 | 0.226 | 0.07 | Retinoic acid alpha receptor agonist | 0.07 0.006 DBMET01128 | DBMET01128 | |
| 0.047 | 0.26 | 0.115 | ABCA1 expression enhancer | 0.115 0.035 DBMET01128 | DBMET01128 | |
| 0.036 | 0.25 | 0.086 | Cyclin-dependent kinase 9 inhibitor | 0.086 0.082 DBMET01089 | DBMET01089 | |
| 0.039 | 0.254 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.069 DBMET01128 | DBMET01128 | |
| 0.119 | 0.335 | 0.306 | Sodium/bile acid cotransporter inhibitor | 0.246 0.132 DBMET00256 0.263 0.115 DBMET01090 0.276 0.101 DBMET01128 0.306 0.073 DBMET01129 | DBMET01129 | |
| 0.04 | 0.255 | 0.134 | GABA receptor agonist | 0.134 0.045 DBMET01089 0.107 0.069 DBMET01129 | DBMET01089 | |
| 0.041 | 0.257 | 0.121 | Protein kinase C gamma inhibitor | 0.101 0.075 DBMET01089 0.121 0.051 DBMET01128 0.119 0.053 DBMET01129 | DBMET01128 | |
| 0.019 | 0.238 | 0.129 | MAP kinase 11 inhibitor | 0.129 0.023 DBMET01089 | DBMET01089 | |
| 0.029 | 0.251 | 0.125 | Inducible nitric-oxide synthase inhibitor | 0.125 0.023 DBMET01089 0.104 0.034 DBMET01129 | DBMET01089 | |
| 0.01 | 0.234 | 0.066 | Prostaglandin E2 antagonist | 0.066 0.025 DBMET01128 | DBMET01128 | |
| 0.009 | 0.234 | 0.052 | Purinergic P2Y14 antagonist | 0.052 0.007 DBMET01128 | DBMET01128 | |
| 0.02 | 0.247 | 0.075 | Sphingosine kinase 2 inhibitor | 0.067 0.025 DBMET01089 0.075 0.018 DBMET01129 | DBMET01129 | |
| 0.059 | 0.287 | 0.166 | Protein kinase (CK1) gamma 3 inhibitor | 0.166 0.073 DBMET01089 0.152 0.087 DBMET01128 0.134 0.109 DBMET01129 | DBMET01089 | |
| 0.09 | 0.319 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.13 DBMET01089 | DBMET01089 | |
| 0.012 | 0.241 | 0.09 | Xanthine dehydrogenase inhibitor | 0.09 0.019 DBMET01128 0.071 0.03 DBMET01129 | DBMET01128 | |
| 0.078 | 0.312 | 0.513 | Antioxidant | 0.226 0.098 DBMET00256 0.253 0.082 DBMET01089 0.217 0.103 DBMET01090 0.265 0.076 DBMET01128 0.513 0.019 DBMET01129 | DBMET01129 | |
| 0.007 | 0.248 | 0.024 | CC chemokine 10 receptor antagonist | 0.024 0.004 DBMET01089 0.015 0.01 DBMET01129 | DBMET01089 | |
| 0.059 | 0.3 | 0.155 | Potassium channel blocker | 0.155 0.13 DBMET01089 | DBMET01089 | |
| 0.072 | 0.313 | 0.158 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.158 0.117 DBMET01089 | DBMET01089 | |
| 0.058 | 0.301 | 0.201 | Insulin sensitizer | 0.167 0.111 DBMET01089 0.168 0.11 DBMET01091 0.201 0.072 DBMET01128 0.187 0.088 DBMET01129 | DBMET01128 | |
| 0.066 | 0.312 | 0.23 | Interleukin 6 antagonist | 0.227 0.029 DBMET01089 0.13 0.124 DBMET01128 0.23 0.028 DBMET01129 | DBMET01129 | |
| 0.034 | 0.28 | 0.077 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.077 0.069 DBMET01128 | DBMET01128 | |
| 0.01 | 0.258 | 0.084 | Glutamate (mGluR3) antagonist | 0.049 0.013 DBMET01089 0.084 0.005 DBMET01128 0.044 0.017 DBMET01129 | DBMET01128 | |
| 0.072 | 0.32 | 0.208 | Streptokinase A inhibitor | 0.208 0.128 DBMET01129 | DBMET01129 | |
| 0.017 | 0.267 | 0.052 | GABA B receptor antagonist | 0.052 0.018 DBMET01089 0.042 0.031 DBMET01128 0.043 0.03 DBMET01129 | DBMET01089 | |
| 0.005 | 0.257 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.031 DBMET01091 | DBMET01091 | |
| 0.005 | 0.257 | 0.033 | Kinesin antagonist | 0.033 0.031 DBMET01091 | DBMET01091 | |
| 0.007 | 0.259 | 0.038 | Retinoic acid receptor agonist | 0.038 0.007 DBMET01128 | DBMET01128 | |
| 0.005 | 0.259 | 0.079 | Urate transporter 1 inhibitor | 0.037 0.029 DBMET01089 0.079 0.008 DBMET01128 0.045 0.022 DBMET01129 | DBMET01128 | |
| 0.008 | 0.262 | 0.146 | Nicotinic acid receptor 2 agonist | 0.146 0.004 DBMET01128 | DBMET01128 | |
| 0.053 | 0.309 | 0.142 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 DBMET00257 0.111 0.102 DBMET01090 0.142 0.068 DBMET01091 0.115 0.097 DBMET01129 | DBMET01091 | |
| 0.016 | 0.28 | 0.06 | HIV-1 reverse transcriptase inhibitor | 0.06 0.059 DBMET01129 | DBMET01129 | |
| 0.018 | 0.283 | 0.057 | Lysine-specific demethylase 1A inhibitor | 0.057 0.032 DBMET01089 0.05 0.045 DBMET01129 | DBMET01089 | |
| 0.025 | 0.295 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.093 0.039 DBMET01128 0.124 0.024 DBMET01129 | DBMET01129 | |
| 0.005 | 0.277 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 DBMET01128 | DBMET01128 | |
| 0.008 | 0.294 | 0.035 | Factor VIIa inhibitor | 0.035 0.029 DBMET01091 | DBMET01091 | |
| 0.016 | 0.308 | 0.086 | DNA gyrase inhibitor | 0.086 0.023 DBMET00257 0.063 0.044 DBMET01090 | DBMET00257 | |
| 0.034 | 0.329 | 0.108 | DNA directed RNA polymerase inhibitor | 0.108 0.048 DBMET01089 0.091 0.067 DBMET01129 | DBMET01089 | |
| 0.025 | 0.324 | 0.124 | Protein kinase C zeta inhibitor | 0.099 0.052 DBMET01089 0.124 0.03 DBMET01129 | DBMET01129 | |
| 0.011 | 0.313 | 0.058 | GABA A receptor antagonist | 0.058 0.033 DBMET01089 | DBMET01089 | |
| 0.017 | 0.325 | 0.069 | CDC25A inhibitor | 0.069 0.059 DBMET01128 0.069 0.059 DBMET01129 | DBMET01129 | |
| 0.096 | 0.405 | 0.365 | Antibacterial | 0.219 0.208 DBMET01089 0.216 0.211 DBMET01091 0.365 0.094 DBMET01128 0.306 0.131 DBMET01129 | DBMET01128 | |
| 0.033 | 0.346 | 0.132 | Xanthine oxidase inhibitor | 0.12 0.047 DBMET01128 0.132 0.042 DBMET01129 | DBMET01129 | |
| 0.01 | 0.326 | 0.06 | GABA receptor antagonist | 0.06 0.032 DBMET01089 0.05 0.045 DBMET01129 | DBMET01089 | |
| 0.02 | 0.344 | 0.093 | Protein kinase B gamma inhibitor | 0.093 0.036 DBMET01091 | DBMET01091 | |
| 0.011 | 0.335 | 0.074 | Glutamate receptor agonist | 0.074 0.059 DBMET01128 | DBMET01128 | |
| 0.019 | 0.348 | 0.15 | RET inhibitor | 0.15 0.062 DBMET00256 0.122 0.078 DBMET01090 | DBMET00256 | |
| 0.003 | 0.336 | 0.015 | Retinoic acid receptor gamma antagonist | 0.015 0.005 DBMET01128 | DBMET01128 | |
| 0.022 | 0.36 | 0.059 | Factor III inhibitor | 0.059 0.019 DBMET01128 | DBMET01128 | |
| 0.004 | 0.348 | 0.034 | Glutamate (mGluR2) antagonist | 0.033 0.017 DBMET01089 0.034 0.016 DBMET01128 | DBMET01128 | |
| 0.059 | 0.406 | 0.377 | Lipoxygenase inhibitor | 0.247 0.102 DBMET01089 0.279 0.082 DBMET01128 0.377 0.043 DBMET01129 | DBMET01129 | |
| 0.009 | 0.361 | 0.096 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.049 DBMET01128 0.096 0.027 DBMET01129 | DBMET01129 | |
| 0.027 | 0.379 | 0.154 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.126 0.095 DBMET01089 0.154 0.074 DBMET01128 0.119 0.102 DBMET01129 | DBMET01128 | |
| 0.005 | 0.36 | 0.1 | Estrogen agonist | 0.1 0.017 DBMET01129 | DBMET01129 | |
| 0.03 | 0.387 | 0.113 | Thioredoxin inhibitor | 0.087 0.066 DBMET01089 0.113 0.036 DBMET01129 | DBMET01129 | |
| 0.006 | 0.364 | 0.116 | Aromatase inhibitor | 0.087 0.025 DBMET01089 0.116 0.019 DBMET01129 | DBMET01129 | |
| 0.015 | 0.374 | 0.056 | Glutamate (mGluR8) antagonist | 0.033 0.032 DBMET01089 0.056 0.006 DBMET01128 | DBMET01128 | |
| 0.066 | 0.433 | 0.257 | Hypoglycemic | 0.257 0.073 DBMET01128 0.253 0.075 DBMET01129 | DBMET01128 | |
| 0.027 | 0.394 | 0.098 | Factor XII inhibitor | 0.098 0.039 DBMET01091 | DBMET01091 | |
| 0.028 | 0.396 | 0.258 | Mcl-1 antagonist | 0.258 0.033 DBMET01128 0.137 0.103 DBMET01129 | DBMET01128 | |
| 0.033 | 0.401 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.092 DBMET01089 | DBMET01089 | |
| 0.004 | 0.375 | 0.054 | Glutamate (mGluR group II) antagonist | 0.045 0.019 DBMET01089 0.054 0.014 DBMET01128 | DBMET01128 | |
| 0.031 | 0.408 | 0.165 | EphB2 antagonist | 0.165 0.115 DBMET01089 0.141 0.139 DBMET01129 | DBMET01089 | |
| 0 | 0.378 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET01128 | DBMET01128 | |
| 0.034 | 0.413 | 0.203 | Estrogen antagonist | 0.108 0.079 DBMET00256 0.104 0.088 DBMET01090 0.203 0.013 DBMET01129 | DBMET01129 | |
| 0.089 | 0.469 | 0.197 | Caspase 3 stimulant | 0.197 0.174 DBMET01129 | DBMET01129 | |
| 0.005 | 0.388 | 0.071 | Antineoplastic antibiotic | 0.071 0.064 DBMET00256 0.071 0.064 DBMET01090 | DBMET01090 | |
| 0.097 | 0.481 | 0.31 | Apoptosis agonist | 0.31 0.165 DBMET00256 0.299 0.173 DBMET01090 0.287 0.182 DBMET01129 | DBMET00256 | |
| 0.039 | 0.425 | 0.184 | Amyloid beta precursor protein antagonist | 0.184 0.069 DBMET01128 0.176 0.076 DBMET01129 | DBMET01128 | |
| 0.025 | 0.417 | 0.152 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.152 0.06 DBMET01129 | DBMET01129 | |
| 0.015 | 0.411 | 0.045 | DNA gyrase subunit A inhibitor | 0.045 0.025 DBMET01128 | DBMET01128 | |
| 0.003 | 0.406 | 0.028 | Retinoic acid receptor antagonist | 0.028 0.006 DBMET01128 | DBMET01128 | |
| 0.023 | 0.432 | 0.193 | Estrogen receptor beta antagonist | 0.097 0.071 DBMET00256 0.193 0.01 DBMET01129 | DBMET01129 | |
| 0.048 | 0.459 | 0.147 | Hepatoprotectant | 0.147 0.113 DBMET01128 0.141 0.12 DBMET01129 | DBMET01128 | |
| 0.035 | 0.447 | 0.178 | Interleukin antagonist | 0.138 0.127 DBMET01091 0.178 0.097 DBMET01129 | DBMET01129 | |
| 0.023 | 0.438 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.08 DBMET01129 | DBMET01129 | |
| 0.004 | 0.422 | 0.024 | Dopamine D1 agonist | 0.024 0.014 DBMET01129 | DBMET01129 | |
| 0.048 | 0.466 | 0.206 | NOS3 expression enhancer | 0.123 0.11 DBMET01128 0.206 0.038 DBMET01129 | DBMET01129 | |
| 0.003 | 0.422 | 0.03 | Retinoic acid alpha receptor antagonist | 0.03 0.007 DBMET01128 | DBMET01128 | |
| 0.017 | 0.442 | 0.05 | Factor IXa inhibitor | 0.05 0.038 DBMET01128 | DBMET01128 | |
| 0.002 | 0.431 | 0.015 | Retinoic acid beta receptor antagonist | 0.015 0.005 DBMET01128 | DBMET01128 | |
| 0.03 | 0.467 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.055 DBMET01129 | DBMET01129 | |
| 0.009 | 0.45 | 0.043 | Estrogen-related receptor beta antagonist | 0.043 0.009 DBMET01129 | DBMET01129 | |
| 0.033 | 0.479 | 0.131 | Interleukin 1 antagonist | 0.131 0.074 DBMET01089 0.121 0.087 DBMET01129 | DBMET01089 | |
| 0.1 | 0.547 | 0.309 | MAP kinase kinase 6 inhibitor | 0.309 0.127 DBMET01089 | DBMET01089 | |
| 0.006 | 0.46 | 0.072 | HIV-1 integrase (Strand Transfer) inhibitor | 0.072 0.035 DBMET01129 | DBMET01129 | |
| 0.028 | 0.488 | 0.143 | DNA polymerase I inhibitor | 0.11 0.077 DBMET01128 0.143 0.053 DBMET01129 | DBMET01129 | |
| 0.031 | 0.491 | 0.166 | Farnesoid X receptor antagonist | 0.166 0.037 DBMET01128 0.161 0.042 DBMET01129 | DBMET01128 | |
| 0.079 | 0.553 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.061 DBMET01128 | DBMET01128 | |
| 0.013 | 0.497 | 0.04 | Guanylate cyclase stimulant | 0.04 0.038 DBMET01128 | DBMET01128 | |
| 0.004 | 0.489 | 0.076 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.076 0.007 DBMET01129 | DBMET01129 | |
| 0.07 | 0.555 | 0.249 | Apoptosis antagonist | 0.236 0.141 DBMET01128 0.249 0.129 DBMET01129 | DBMET01129 | |
| 0.041 | 0.534 | 0.106 | Folate antagonist | 0.106 0.055 DBMET01128 | DBMET01128 | |
| 0.033 | 0.528 | 0.156 | Nitric oxide antagonist | 0.156 0.09 DBMET01129 | DBMET01129 | |
| 0.026 | 0.522 | 0.077 | Thioredoxin reductase inhibitor | 0.077 0.07 DBMET01129 | DBMET01129 | |
| 0.005 | 0.507 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | 0.035 0.02 DBMET01128 | DBMET01128 | |
| 0.01 | 0.523 | 0.131 | Purinergic P2X2 antagonist | 0.064 0.049 DBMET01089 0.082 0.039 DBMET01128 0.131 0.017 DBMET01129 | DBMET01129 | |
| 0.01 | 0.545 | 0.155 | Dyrk kinase inhibitor | 0.155 0.131 DBMET01129 | DBMET01129 | |
| 0.009 | 0.55 | 0.16 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.16 0.122 DBMET01129 | DBMET01129 | |
| 0.006 | 0.564 | 0.043 | Estrogen-related receptor alpha antagonist | 0.043 0.016 DBMET01129 | DBMET01129 | |
| 0.036 | 0.594 | 0.081 | Transforming growth factor beta 3 antagonist | 0.081 0.062 DBMET01089 | DBMET01089 | |
| 0.031 | 0.592 | 0.171 | Interleukin 4 antagonist | 0.108 0.104 DBMET01128 0.171 0.035 DBMET01129 | DBMET01129 | |
| 0.006 | 0.569 | 0.103 | Alpha tubulin antagonist | 0.103 0.015 DBMET01129 | DBMET01129 | |
| 0.002 | 0.571 | 0.109 | Estrogen receptor beta agonist | 0.109 0.01 DBMET01129 | DBMET01129 | |
| 0.018 | 0.6 | 0.254 | Angiogenesis stimulant | 0.245 0.072 DBMET01128 0.254 0.068 DBMET01129 | DBMET01129 | |
| 0.01 | 0.594 | 0.284 | Protein-tyrosine phosphatase inhibitor | 0.284 0.022 DBMET01128 0.151 0.077 DBMET01129 | DBMET01128 | |
| 0.002 | 0.613 | 0.089 | Estrogen receptor alpha agonist | 0.089 0.01 DBMET01129 | DBMET01129 | |
| 0.004 | 0.623 | 0.094 | Beta tubulin antagonist | 0.094 0.024 DBMET01129 | DBMET01129 | |
| 0.004 | 0.634 | 0.119 | Peroxisome proliferator-activated receptor gamma agonist | 0.119 0.02 DBMET01128 | DBMET01128 | |
| 0.006 | 0.64 | 0.061 | Plasminogen activator inhibitor antagonist | 0.061 0.023 DBMET01128 | DBMET01128 | |
| 0.005 | 0.641 | 0.211 | Protein-tyrosine phosphatase 1B inhibitor | 0.211 0.026 DBMET01128 0.091 0.088 DBMET01129 | DBMET01128 | |
| 0.006 | 0.646 | 0.081 | CDC25B inhibitor | 0.081 0.027 DBMET01128 | DBMET01128 | |
| 0.043 | 0.685 | 0.156 | MAP kinase kinase 4 inhibitor | 0.13 0.115 DBMET01128 0.156 0.05 DBMET01129 | DBMET01129 | |
| 0.006 | 0.658 | 0.118 | Glutamate receptor antagonist | 0.118 0.076 DBMET01128 | DBMET01128 | |
| 0.006 | 0.702 | 0.138 | Tubulin antagonist | 0.138 0.065 DBMET01129 | DBMET01129 | |
| 0.007 | 0.708 | 0.484 | Cyclooxygenase 1 inhibitor | 0.484 0.005 DBMET01089 0.364 0.009 DBMET01128 0.461 0.005 DBMET01129 | DBMET01089 | |
| 0.019 | 0.739 | 0.123 | MAP3K9 inhibitor | 0.123 0.109 DBMET01128 | DBMET01128 | |
| 0.006 | 0.733 | 0.089 | Bronchodilator | 0.089 0.076 DBMET01090 | DBMET01090 | |
| 0.013 | 0.745 | 0.174 | Insulin secretagoues | 0.174 0.052 DBMET01128 | DBMET01128 | |
| 0.009 | 0.781 | 0.126 | Thrombolytic | 0.126 0.103 DBMET01128 | DBMET01128 | |
| 0.006 | 0.783 | 0.372 | Cyclooxygenase inhibitor | 0.372 0.009 DBMET01089 0.298 0.018 DBMET01128 0.342 0.012 DBMET01129 | DBMET01089 | |
| 0.005 | 0.784 | 0.103 | 5-Lipoxygenase inhibitor | 0.103 0.061 DBMET01129 | DBMET01129 | |
| 0.005 | 0.86 | 0.159 | Uric acid excretion stimulant | 0.159 0.02 DBMET01128 | DBMET01128 | |
| 0.008 | 0.898 | 0.389 | Cyclophilin D inhibitor | 0.389 0.097 DBMET01128 0.259 0.203 DBMET01129 | DBMET01128 | |
| 0.01 | 0.902 | 0.385 | Antiinflammatory | 0.385 0.148 DBMET01128 0.36 0.165 DBMET01129 | DBMET01128 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |